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Avian Influenza: It is Still a Problem in 
Three Continents. 
K.A. Schat 
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Highly pathogenic avian influenza (HPAI) has 
attracted world-wide interest in first instance 
since 1996/97 and especially since 2003. The 
appearance of the Asian lineages of H5N1 
HPAI virus (referred to in this paper as H5N1 
HPAIV) has instilled wide-spread fear in many 
political, scientific and other circles that a 
deadly flu pandemic is at our doorstep. In 2009, 
this fear was replaced by the occurrence of 
H1N1 Mexican flu virus, which became the 
new pandemic flu virus and, as a consequence, 
the threat of a H5N1 HPAIV pandemic 
disappeared from the mainstream press. 
Although the pandemic has not (yet) occurred, 
H5N1 HPAIV has caused the dead of untold 
free-living birds and poultry since 2003 as well 
as a very low infection rate in humans albeit 
with a high fatality rate. In this review, I will 
first address the current information on the 
incidence of H5N1 HPAIV in humans followed 
by an update on the situation in free-living 
birds and poultry. Finally, I will discuss the 
possible reasons for the absence of this 
particular subtype of AIV in Australia. Detailed 
information on H5N1 HPAIV can be found in 
recent review papers on the ecology of AIV (4), 
outbreaks and biological properties (5), and 
pathogenesis with a focus on the disease in 
humans (7). 
The incidence of H5N1 in humans has 
fluctuated from 2003 to May 6 2010 between 4 
and 115 cases in 2003 and 2006, respectively. 
The total incidence remains low with 498 
confirmed cases and 59% mortality (10). In 
2010, the WHO reported thus far 30 cases in 4 
countries (Cambodia, Egypt, Indonesia and 
Vietnam) with a 40% fatality rate. The majority 
of these cases (63%) occurred in Egypt (10). 
Clearly, the disease remains present in humans 
and the risks remain real that the virus mutates 
to allow sustained human-to-human 
transmission. 
The situation in poultry and free-living birds is 
less clear than the overview for human cases. 
The OIE reports outbreaks in 51 countries 
representing 3 continents since 2003 with 19 
countries reporting more than 20 outbreaks 
during this period (6). On the other hand, Sims 
and Narrod (9) mentioned that “some 60 
countries” have been affected. During the 
period of October 29, 2009 to April 29, 2010 
the FAO (1) reported outbreaks in 14 countries 
with many of these outbreaks occurring in 
South-east Asia, including Indonesia, and the 
Indian subcontinent (Fig. 1). The actual number 
of outbreaks is probably higher than the 
reported numbers and some countries may not 
report all outbreaks to the OIE. Intensive 
surveys of free-living birds have been 
conducted in America and Australia to 
determine if H5N1 HPAIV is present in birds. 
Thus far, this subtype has not been detected in 
America (4) and Australia (2).  
In order to better understand the reasons why 
these two continents have remained free of 
H5N1 HPAIV it will be important to examine 
the ecology of avian influenza viruses. The 
major natural reservoirs of avian influenza 
viruses consist of two orders of birds: the 
Anseriformes and the Charadriiformes. The 
later order has 13 families comprising 91 
genera with approximately 340 species. 
Important families in this group are the 
sandpipers and terns and gulls. These birds 
migrate often over large distances: for example 
the black-tailed and bar-tailed godwits may 
breed in the tundra’s of Siberia and spend the 
northern winters in balmy Australia. The 
Anseriformes consist of 3 families with the 
Anatidae being the largest family consisting of 
140 species of ducks, geese, and swans. The 
Anseranatidae consists of only one species: 
the Magpie Goose. In contrast to Europe, 
Africa and the Americas where ducks, swans 
and geese migrate between summer and winter 
seasons, most of the ducks in Australia do not 
regularly leave the continent with two 
exceptions: the wandering whistling ducks and 
the magpie goose (8). The latter is susceptible 
to experimental infection with H5N1 HPAIV 
resulting in clinical disease and mortality (D. 
Middleton, AAHL, personal communication). 
Munster and Fouchier (4) indicated that ducks 
infected with H5N2 HPAIV were able to 
migrate more than 650 km and it therefore 
conceivable that infected magpie geese can 
introduce H5N1 HPAIV into Australia. It has to 
be realized that many other species of free-
living birds can become infected and die as a 
consequence.  It is not known how soon after 
infection these birds become clinically ill or if 
they do not become sick if they can transmit the 
virus. 
 
 
Fig 1. Outbreaks of H5N1 HPAI during the period of 29-10-2009 to 29-4-2010. 
(http://www.fao.org/avianflu/en/maps.html, Accessed May10, 2010) 
 
 
 
 
 
 
 
 
 
 
Munster and Fouchier (4) reviewed the ecology 
of AIV and offered some interesting insights 
into the differences between the Anseriformes 
and the Charadriiformes as ecological 
reservoirs for AIV. The Charadriiformes, and 
especially the gulls and terns, are the natural 
hosts for the H13 and H16 subtypes, while the 
Anseriformes are the natural host for the other 
14 subtypes. However, this separation is not 
absolute and AIV subtypes other than H13 and 
H16 viruses have been isolated from sandpipers 
in Australia. For example, Hurt et al (2) 
obtained H4N8 isolates from red-necked stints 
and H11N9 isolates from sharp-tailed 
sandpipers, but these viruses were low 
pathogenic. It is currently unknown how 
widespread infection with subtypes other than 
H13 and H16 is in Charadriiformes. 
Experimental infection of ducks with gull 
viruses indicated that ducks are not highly 
susceptible to these viruses, which may be 
related to subtle differences in the HA receptors 
between these viruses (reviewed in 4). 
However it is unknown how susceptible 
Charadriiformes are to infection with any of the 
14 subtypes associated with ducks. It is also not  
 
 
 
 
 
 
 
 
 
 
 
known how often these birds co-mingle on the 
breeding grounds with dabbling ducks in Asia 
prior to migrating to Australia. In addition it is 
not known how these viruses and especially 
H5N1 HPAIV would affect the ability of long-
range migrants to reach Australia. Answers to 
these questions are essential to address the 
question how easy H5N1 HPAIV can be 
introduced in Australia by free-living birds. On 
the other hand introduction of the virus by 
fishing boats from Indonesia may constitute a 
far greater risk to native duck populations.  
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Avian Influenza Vaccination – Preparing 
For an Outbreak 
Dr Kathy Gibson 
Office of the Chief Veterinary Officer, 
Department of Agriculture, Fisheries and Forestry 
Canberra ACT 
Introduction 
The Australian government has been enhancing 
preparedness activities for avian influenza since 
widespread outbreaks of H5N1 highly 
pathogenic avian influenza (HPAI) were 
reported in Asia from 2003. These 
preparedness activities have included re-
evaluation of the role of vaccination in control 
of avian influenza (AI) of the H5 and H7 
subtypes. 
Australia has had five outbreaks of HPAI in the 
past. Each of these outbreaks was eradicated by 
stamping out (destruction of infected flocks) 
without vaccination. Australia’s preferred 
approach to an outbreak of HPAI or low 
pathogenicity AI (H5 or H7) is to eradicate the 
virus without vaccination. However, 
vaccination would be considered in the event of 
a large, rapidly spreading outbreak of either 
HPAI or LPAI (H5 or H7) in Australia.  If a 
decision is made to vaccinate, the strategic 
priority will be to stop the spread of the 
outbreak and to protect rare, endangered, and 
valuable birds. 
Recognising the growing importance of 
vaccination in controlling emergency animal 
diseases, the Animal Health Committee formed 
a national AI vaccine expert (NAIVE) group  to 
provide advice on vaccination, refine 
vaccination policy and keep a watching brief on 
vaccine developments. NAIVE is coordinated 
by the Australian Government Department of 
Agriculture, Fisheries and Forestry, and group 
members include consultants to the poultry 
industry with particular expertise in vaccines 
and vaccination, as well as members from state 
and Commonwealth governments.  
Regulatory approval of AI 
vaccines  
The Australian Chief Veterinary Officer 
currently holds import permits for emergency 
use for four inactivated AI vaccines – Intervet 
Nobilis Influenza H5 (H5N2), Intervet Nobilis 
Influenza H7N1, Pfizer (Fort Dodge) Poulvac 
Flufend i AI H5N9 and Pfizer Poulvac Flufend 
i AI H7N1. All four vaccines are also registered 
with the APVMA for emergency use in 
Australia. If these vaccines are ordered in 
response to an outbreak of AI (H5 or H7), they 
may only be released from a quarantine-
approved premises with the written 
authorisation of the Chief Veterinary Officer 
following a decision by the Consultative 
Committee for Emergency Animal Diseases 
(CCEAD) to use vaccination as part of an 
emergency response to an outbreak.  
Process of selection of AI 
vaccines 
Vaccines suitable for use in Australia were 
selected based on a number of considerations. 
The preference was for a vaccine that was 
registered or approved in a reputable country 
(for example, the United States or Europe), for 
which safety and efficacy data were available, 
as well as evidence of good manufacturing 
processes. Inactivated vaccines generally result 
in a stronger immune response than the 
genetically modified vaccines available at the 
time. Potential delays in getting regulatory 
approval for genetically modified vaccines for 
food-producing animals, as well as issues with 
consumer acceptance, were taken into account 
during the selection of suitable vaccines.  
Decision support tool for AI 
vaccination 
A decision-support tool has been developed to 
assist CCEAD to determine if vaccination 
should be used as part of an eradication 
program in the event of an outbreak of AI due 
to an H5 or H7 subtype. The decision support 
tool takes into account the location of the 
outbreak (e.g. in an area of low or high poultry 
density), likelihood of spread, availability of 
vaccine and resources, public reaction to a 
stamping out policy and so on. The decision 
support tool has been used in desk-top 
simulations of outbreak scenarios and is 
currently available for comment by industry.  
National operating procedures for 
AI vaccination  
A set of draft national operating procedures 
(NOPs) has been developed by the NAIVE 
group as a basis for discussion with industry. 
Once agreed between industry and Animal 
Health Committee, this document will be 
linked to AUSVETPLAN and will form part of 
the nationally agreed response to an outbreak. 
The document will also be used to develop 
detailed standard operating procedures for entry 
and exit procedures from farms, biosecurity 
arrangements for vaccinators, pre-vaccination 
testing and post-vaccination monitoring of 
flocks, and so on.  
The draft NOPs describe principles for 
vaccinating commercial and non-commercial 
poultry within an area subject to an emergency 
response plan. The document covers who can 
authorise vaccination; the importation and 
distribution of AI vaccine and under what 
circumstances it will be released from 
quarantine; pre-vaccination testing of flocks (to 
ensure the flock to be vaccinated is not already 
infected); movement controls for vaccinated 
flocks and their products; monitoring and 
testing of vaccinated birds; testing to prove 
freedom once the outbreak is eradicated; 
inventory control and exit strategy from the 
vaccine campaign.  
Because of the nature of the vaccine (requiring 
administration to individual birds) and the 
length of time required for development of 
immunity, it is likely that longer-lived flocks, 
such as breeders, layers and turkeys, would be 
targeted for vaccination during an emergency 
response. It is possible to vaccinate short-lived 
birds, however, if such flocks are at risk from 
spread of AI virus, it may be logistically more 
practical to depopulate or send them for early 
processing. 
Vaccination carried out as part of the 
emergency response would funded from cost-
sharing arrangements.  
Vaccination of flocks outside the 
emergency response 
The poultry and zoo industries have expressed 
interest in having access to vaccine to protect 
valuable or rare birds from avian influenza in 
the event of an outbreak occurring in Australia. 
These flocks may not necessarily be situated in 
an area subject to an emergency response, or, if 
they are within such an area, may not be 
otherwise considered for vaccination as part of 
the response plan.  
A draft document, currently with industry 
groups for comment, takes into account 
proposals to vaccinate flocks or birds ‘outside’ 
the emergency response plan. Applications to 
vaccinate such flocks would be evaluated on a 
case-by-case basis by CCEAD, taking into 
account national and state interests, vaccine 
availability, risk of exposure to AI, and other 
factors. Flocks vaccinated outside an 
emergency response plan would be vaccinated 
at the expense of their owners. They would be 
subject to movement controls, may be required 
to accommodate unvaccinated sentinel birds, 
and would undergo monitoring and testing, also 
at the owners’ expense. The frequency of 
monitoring would be risk-based and depend on 
individual circumstances, including flock size, 
proposed movements of products or birds, 
biosecurity level and so on. 
Vaccination of zoo birds 
A draft document on vaccinating zoo 
collections, captive rare breeds and endangered 
species is currently under consideration by the 
zoo industry. Procedures for application, 
vaccination and testing of the zoo birds are 
similar to those described for vaccination 
outside the emergency response, and the cost of 
vaccination and testing would be borne by the 
owners of the bird collection.  
Administration of vaccines 
The NAIVE group has had discussions with 
commercial poultry vaccination companies 
about the practicalities of administering AI 
vaccines to uninfected flocks during an 
emergency response. While some larger poultry 
companies are able to supply their own 
vaccination staff, NAIVE recognises that the 
use of commercial vaccination crews in an 
emergency could enhance the efficiency of 
vaccination, welfare of birds being vaccinated, 
the number of birds that can be vaccinated, as 
well as providing access to trained poultry 
handlers, vaccinators and other contacts within 
the poultry industry. Some commercial 
vaccination crews have agreed to provide input 
during the development of standard operating 
procedures for AI vaccination, and to supply a 
core of staff to assist in training of vaccinators 
in an emergency. NAIVE also recognises the 
need for such companies to maintain business 
continuity during an outbreak by reserving 
‘clean’ crews to service their usual clients.  
Vaccine supply 
At the time of selection of the four vaccines 
registered for emergency use in Australia, each 
of the vaccines was maintained in a ready-to-
use form by the vaccine manufacturers. 
However, both Intervet and Pfizer have 
recently advised the Office of the Chief 
Veterinary Officer that they no longer stock 
ready-to-use H7N1 vaccines, and that the time 
to manufacture and safety testing of a batch of  
vaccine could be 4-6 months from the date of 
order. Therefore, despite careful vaccine 
selection and regulatory approval, Australia 
does not currently have access to a ready 
supply of vaccine against an H7 AI virus. The 
next step in our vaccination preparedness plans, 
therefore, is to revisit the subject of 
contingency vaccine supply options with 
industry, state governments and vaccine 
manufacturers.  
 
The National Newcastle Disease 
Management Plan - 2002 to 2012 
Clive A W Jackson 
Biological Technology Transfer Pty Ltd 
2 Victory Ave, Camden NSW 2570 
SUMMARY.   
Australia developed a National ND 
Management Plan (NNDMP) (the "Plan") from 
2003 to attempt to eradicate and prevent the re-
emergence of precursor and virulent ND virus 
(vNDV). Because of the potential for vNDV re-
emergence and a decision that a test and 
slaughter approach would not be successful, a 
vaccination strategy using the live lentogenic 
strain V4 and inactivated ND vaccines was 
developed to out-compete precursor viruses 
that have a closely related sequence to that of 
the vNDV. The extent to which vaccination can 
prevent the spread of precursor virus is 
paramount to the success of the program. The 
Plan has now been revised three times. This 
paper describes the origins of the Plan and the 
progress that the Plan has made over the past 
eight years in preventing ND and looks ahead 
towards the end of the current Plan in 2012 
when the possibility of a cessation of ND 
vaccination could be realised.   
INTRODUCTION 
Australia would appear to have 
experienced a rather unique event in terms of 
the mutation of vNDV from an endemic 
lentogenic strain. The factors that encouraged 
precursor and vNDVs to emerge are not well 
understood, although flock immunosuppression 
due to concurrent MDV, IBDV or CAV 
infection has been suggested to alter selection 
pressure during virus propagation through the 
flock, assisting evolution to virulence. 
Alternatively, it has been suggested that vNDV 
may have emerged slowly in accordance with 
the quasi-species concept with evolutionary 
selection pressures on a heterogeneous 
population of NDVs causing those sub-
populations to emerge that are best adapted to 
the changing poultry growing environment. 
Because of the potential for vNDV re-
emergence, a vaccination strategy was 
developed that aimed to out-compete precursor 
viruses that have a fusion protein gene 
sequence similar to that of the virulent virus.  
A Government Industry Technical 
Working Group developed extensive standard 
operating procedures (SOPs) during the period 
1999-2000 to effect ND control in NSW when 
Australia had no national policy to control 
vNDV arising out of an endemic strain. 
Reluctance by government to implement 
compulsory vaccination was heavily criticised 
at the time. However, a national survey in 2000 
indicated that vNDV and progenitor viruses 
were not widespread. Further outbreaks from 
vNDV in Victoria and NSW in 2002 forced the 
issue and out of an Emergency Animal Disease 
response Agreement (EADRA), a request was 
made to Animal Health Australia (AHA) to 
develop a management plan including 
compulsory vaccination. AHA appointed a 
Steering Committee to develop the Plan. 
THE NATIONAL ND 
MANAGEMENT PLAN 
In 2003, the Steering Committee of the 
NDNMG recommended an integrated risk-
managed approach to ND prevention. The 
integrated risk management approach was 
aimed to deliver the following goals: 
a) Minimise the risk of ND outbreaks from 
Australian-origin virulent viruses 
b) Protect the status of non-infected flocks and 
regions; and  
c) Reduce the social, economic and trade 
impact of ND at farm, regional and national 
levels. 
 
The operational projects to deliver these 
goals comprised: 
1. A control project involving biosecurity 
plans, strategic vaccination and other 
agreed standard operating procedures 
(SOP). 
2. A national surveillance project to detect the 
presence of precursor and virulent ND 
viruses.  
3. A communication project to promote 
awareness in the poultry industry. 
4. A research and development project to 
support the Plan. 
5. A management and evaluation project to 
provide co-ordination and review 
implementation of the Plan.  
 
In the 2005-2007 Plan, more specific 
targets were set including: 
♦ the application of poultry industry 
biosecurity plans 
♦ the strategic application and monitoring of 
vaccination 
♦ nationally coordinated surveillance to 
identify the location of precursor viruses 
♦ communication and awareness to promote 
early detection of ND 
♦ a review of the implementation of the Plan. 
 
The 2008-2012 Plan included the same 
components of the previous Plan together with 
some reduction in compulsory vaccination in 
states considered to be of lower risk. It also 
included a risk-based exit strategy that will 
potentially minimise or eliminate vaccination 
as a requirement to prevent outbreaks of 
Australian-origin ND. The risk-based exit 
strategy includes an assessment of existing and 
planned surveillance data to support the current 
program and proposed changes into the future.   
REGULATORY VACCINATION 
REQUIREMENTS 
ND vaccination was introduced in 
NSW in 1999 became compulsory around 
Sydney in 2002 and throughout NSW in 2003. 
However, it was not until 2005 that all 
Australian states required commercial poultry 
to follow mandatory vaccination programs as 
described in a set of SOPs developed by the 
NDMG. The SOP for ND vaccination of broiler 
chickens recommended that chickens be 
preferably vaccinated with live V4 strain ND 
vaccine at 7-14 days of age. However, the SOP 
also allowed farmers the option of vaccinating 
at day-old provided they can show evidence of 
equivalence to the preferred program. The latter 
program retains control of ND vaccination in 
hands of the hatchery where it has been claimed 
that improved uniformity and lower cost can be 
achieved than through administration by 
drinking water undertaken by broiler growers. 
Adequacy of the response to vaccination is 
defined as the mean haemagglutination 
inhibition (HI) titre of the flock being at least 
log 2 3 with at least 66% of the individual 
samples reaching a HI titre of 2 3 by 35 days of 
age. Commercial layer and breeding flocks 
were to be vaccinated with inactivated ND 
vaccine after initial priming with live V4 
vaccine. 
ISSUES ARISING DURING THE 
IMPLEMENTATION PHASES 
A review of the Plan in 2006 by 
Andrew Turner Consulting concluded that the 
Plan had achieved a major goal in preventing 
outbreaks of ND since 2002. The review also 
identified a number of deficiencies in the Plan. 
These included dissension within the industry 
and government agencies as to the direction of 
the Plan, the choice of V4 vaccine or its method 
of administration providing sub-optimal 
protection against precursor viruses especially 
in broiler chickens, inadequate data on vaccine 
usage, the lack of a targeted surveillance 
program, a need for an improved and audited 
biosecurity program and an appropriate exit 
strategy.  
The Steering Committee agreed that 
there was a need for a risk analysis to modify 
the Plan and that there were major 
discrepancies in the usage of vaccine and the 
numbers of birds to be vaccinated across 
Australia. However, some recent studies by 
Arzey and Arzey (2008) refuted the concerns 
about the efficacy of V4 vaccine in broiler 
chickens. The Committee agreed that 
recommendations from the review would be 
considered in the Plan beyond 2007.  
In 2008, the Steering Committee 
embarked on a new Plan for 2008-2102 that 
included a three-tier risk-based assessment of 
the vaccination programs required for states 
perceived to be at a lower risk than NSW and 
Victoria. It was proposed (at level 1) that 
compulsory vaccination of broilers be removed 
in Tasmania and Western Australia (WA). This 
would also include voluntary use of killed ND 
vaccination of laying flocks. At level 2, in 
South Australia and Queensland, compulsory 
use of killed ND vaccine in layers would be 
removed but that regular use of live vaccine 
would be a compulsory alternative coupled 
with monitoring. At level 3 in NSW and 
Victoria the vaccination SOPs would not 
change. These changes were supported by a 
risk assessment and were supported by a 
proposed surveillance plan. The AHC endorsed 
the new Plan after a risk assessment for the 
proposed changes in SA and Queensland 
indicated the risk of vNDV or progenitor virus 
existing in those states was of low risk. The 
Risk Assessment also indicated that the overall 
risk in other jurisdictions including NSW and 
Victoria was very low. An evaluation of a 
surveillance program remained incomplete until 
testing was undertaken in WA and Tasmania. 
Procedures were put in place for an improved 
evaluation of compliance to the vaccination 
SOPs. The Plan is due for mid-term review 
later in 2010 where further consideration will 
be given to an exit strategy, the surveillance 
plan report outcomes, vaccine usage 
compliance (only for layers) and the inclusion 
of endemic NDV in the EADRA.   
FUTURE DIRECTIONS 
Generally, it was felt that the success of 
the risk-based strategy proposed in the Plan 
would depend upon a number of factors, some 
of which are related to the biology of the virus, 
and others dependent upon the enthusiasm with 
which the poultry industry and government face 
the problem. Shifts in virus population 
dynamics from ND vaccination have previously 
been proposed and the removal of vaccination 
could unmask progenitor or vNDVs that have 
been shown to exist within quasi-species 
populations. We may be fortunate that selection 
pressures that existed in the 1990s now no 
longer exist. However, a precautionary  
approach has been taken in the Plan in the 
likelihood that the risks are greater than can be 
calculated. Failure to communicate with the 
other sectors of the poultry industry on the need 
to vaccinate and maintain high levels of 
biosecurity could allow precursor virus to 
persist and prevent total eradication although 
history is perhaps against this occurring. 
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Poultry Council 
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Introduction 
The International Poultry Council (IPC) was 
formed in 2006, with the intention of bringing 
together poultry industry leaders from around 
the world to discuss and address issues of trade, 
science, and to improve relations among 
poultry producing nations. 
The stated objectives of the IPC are to 
strengthen communication between the 
industries of different countries, to develop and 
recommend policies affecting the poultry 
industries of all countries, and to promote a 
common global understanding of and 
confidence in poultry products as the preferred 
source of meat protein. 
The IPC meets twice a year. Outside of 
meetings, activities of the IPC are coordinated 
by its Executive Committee and convenors of 
several working parties. 
ACMF’s Participation in the IPC 
The ACMF joined the IPC in 2007 and has 
attended five of its meetings, the most recent 
being held in Paris on 14th – 16th April 2010. 
The ACMF in fact hosted the previous IPC 
meeting in Sydney in October 2009. Vivien 
Kite represents the ACMF on the IPC, and was 
elected to the Executive Committee of IPC at 
its Sydney 2009 meeting. She also convenes the 
IPC’s informal working groups on animal 
welfare and has responsibility for leading IPC 
activities relevant to OIE’s activities in the food 
safety area.  
Membership  
The IPC now has 23 member countries, 
including the world’s largest producers, users 
and traders in chicken meat, including the four 
largest producers (USA, China, Brazil, EU, 
Mexico), the six largest consumers (USA, 
China, EU, Brazil, Mexico and Russia), and the 
eight largest exporters (Brazil, USA, EU, 
Thailand, China, Argentina, Canada, Chile) of 
chicken meat in the world.  
Associate membership of the IPC now includes 
an increasing number of major individual 
suppliers to and customers of the industry, 
including Cobb-Vantress, Aviagen, Cargill, 
Yum! and McDonalds, as well as several major 
producers, such as Tyson Foods.  
Delegates from 19 countries attended the recent 
Paris 2010 meeting, as did representatives of 
the majority of associate members. 
Recognition of IPC by 
Intergovernmental Bodies 
During the Paris 2010 meeting, a memorandum 
of understanding was signed between the IPC 
and the Food and Agriculture Organization of 
the U.N. (FAO), which officially recognises the 
IPC as the international organisation with 
which the FAO will confer when addressing 
issues relevant to the poultry industry. This is 
the third international policy and standards 
setting organisation which has officially 
recognised IPC. In 2008 the IPC gained the 
recognition of the OIE. The IPC has also been 
officially recognised by the Codex 
Alimentarius Commission. Recognition by 
these organisations generally gives IPC 
observer status in their consideration of issues 
and the ability to provide greater input into 
standards or policies developed by them. It also 
provides expanded opportunities for the 
world’s poultry industries to contribute to the 
work of these organisations’ various working 
and expert groups. For example, the IPC was 
invited to participate in two OIE ad hoc 
working groups over the past year - one on 
private standards in animal health and animal 
welfare, and the other to develop a standard on 
Animal Welfare and Chicken Production 
Systems. Dr Thomas Janning (Germany) 
represented IPC on both of these working 
groups.  
 
The IPC is also seeking recognition from the 
World Health Organisation. 
IPC Activities and International 
Developments 
 
OIE  
The first draft of a new OIE Terrestrial Animal 
Health Code chapter on Animal Welfare and 
Chicken Broiler Production was developed by 
the ad hoc working group referred to above at 
its first meeting in June 2009. IPC member 
country comments on this first draft are 
currently being compiled so as to provide input 
into the ad hoc working group’s next meeting 
in June 2010. Where consensus across the 
membership cannot be achieved, IPC input into 
the second draft of the document will be 
worked through with members at the IPC’s 
next meeting in October 2010. Following 
consideration of comments from member 
countries and supporting organisations (such as 
IPC), this new chapter may be considered for 
adoption in May 2011. 
There are several existing Chapters of the 
OIE’s Terrestrial Animal Health Code that are 
relevant to poultry welfare (eg Chapter 7.3 
Transport of Animals by Land; Chapter 7.5 
Slaughter of Animals; Chapter 7.6 Killing of 
Animals for Disease Control Purposes). As 
these periodically come up for review, 
Australian industry is in a strong position to 
have input into them through our IPC 
involvement, as well as through our own 
national processes (led by DAFF). 
A revision of two existing OIE Terrestrial 
Animal Health Code chapters relevant to 
Salmonella control in poultry (to be 
consolidated into a single draft chapter - 
Chapter 6.5 Prevention, Detection and Control 
of Salmonella in Poultry) will be put up for 
adoption at the General Session of the OIE at 
its meeting in June 2010. While there is no 
opportunity for input by IPC into this chapter at 
this late stage, Chapter 6.4 of the OIE Code 
(Hygiene and Biosecurity Procedures in Poultry 
Production) is currently being reviewed and 
IPC will be given an opportunity to provide 
input into the revised chapter following its 
public release later in 2010.  
The OIE has published guidelines to support 
the practical application of the concept of 
compartmentalisation (TAHC Chapter 4.4 
Application of Compartmentalisation) and is 
involved in two pilot projects on 
compartmentalisation in the poultry sector. 
These two projects (one for AI and the other for 
both AI and ND) are being undertaken by the 
two countries concerned (Brazil and Thailand), 
with OIE providing technical advice. The 
reports of these two projects will be 
confidential to the countries concerned. 
However, in their country’s report to the IPC, 
the delegation from Thailand indicated that 
technical feedback received from the OIE so far 
has suggested that they still had some way to 
go in terms of implementation of HACCP 
principles at the (meat chicken) farm, and also 
the extension of the biosecurity management 
system and HACCP arrangements to the 
breeding farms supplying the meat farms in the 
compartment.  
 
Codex  
In the course of 2009, Codex Alimentarius 
released a report on Salmonella and 
Campylobacter in Chicken Meat. In its 
assessment of the Codex draft ‘Guidelines for 
control of Campylobacter and Salmonella spp. 
in chicken meat’ the expert committee that 
undertook the scientific review of the draft 
guidelines questioned the value of chlorination 
as a means of controlling these pathogens at 
key points in processing. The status of chlorine 
for disinfection of carcasses in processing 
remains unresolved. Al Yancy (USA) will be 
representing IPC in any further work on these 
Codex draft Guidelines.  
 
GMOs 
As is the case in Australia, products derived 
from animals fed GM feed ingredients do not 
have to be labelled as GM in the EU. However, 
this year, the EU will be looking into extending 
the labelling requirements to end-products 
which have come from animals fed GM feed 
ingredients. If endorsed, this will apply to 
imported animal food products as well as 
locally produced products. 
Given the strongly held views of some EU 
poultry producing industries that they should 
maintain a ‘non-GM’ policy, it is unlikely that 
IPC will be able to develop or progress a 
common policy and communications activities 
with respect to the GM issue. 
 
Poultry Meat Promotion 
One of the IPC’s objectives is to promote a 
common global understanding of and 
confidence in poultry products as the preferred 
source of meat protein. While no major 
initiatives in this area have yet been 
undertaken, the IPC will be initiating an annual 
marketing award, commencing in April 2011, 
one aim of which will be to share 
communications, educational and promotional 
materials and ideas which may be extended 
globally, or which may simply be adopted by 
other member counties. 
World Trade and Production 
Trends and Policy Developments 
One of the major benefits of ACMF’s 
involvement with the IPC is that it enables the 
Australian industry to gain a better 
understanding of trends in world production 
and trade in poultry products and to obtain 
insights into evolving issues and policy 
developments around the world which have the 
potential to impact on our own industry in the 
future. The member country reports which are 
delivered at every second IPC meeting are an 
invaluable source of this information, as are the 
informal discussions held with delegates at all 
meetings. As an example, the major concerns of 
the EU poultry industries often revolve around 
impending or recent changes in EU legislation. 
At the moment, there is considerable concern 
regarding the implementation of EU Regulation 
2160/2003 – Annex II, which requires, by 12 
December 2010, the absence of Salmonella in 
25g of fresh chicken and turkey meat. It is not 
clear yet how this regulation will be applied 
(for example, whether it will only be applied to 
certain critical serovars such as Enteritidis and 
Typhimurium), and the industry is hoping for 
clarification of this in the near future.   
The implementation of a recent EU regulation 
on electrical stunning criteria (which sets 
defined currents to be applied at various 
frequencies) has had serious impacts on product 
quality, which has led to a major search for 
alternative approaches, with some promising 
alternatives being develop in the Netherlands in 
particular.   
Further details on the markets, statistics and 
regulatory environment of the poultry 
industries in each of the member countries are 
contained in the country reports from the IPC’s 
most recent meeting (Paris 1010) which are 
held by the ACMF.   
Conclusions 
The IPC is a young organisation, but one which 
is growing in membership and is increasingly 
being recognised as the peak international body 
representing the interests of the poultry meat 
industries globally. Participation in the IPC and 
its meetings has provided us with new 
opportunities to understand developments in 
the poultry industry globally, and to input into 
international standards and policy setting 
processes. The ACMF has recently committed 
to retain its membership of the IPC, and to 
strengthen its participation by attendance at all 
IPC general session meetings, at least until the 
end of 2011. 
Poultry Disease and Control in Overseas 
Countries – Relevance to Australia 
Tom Grimes 
Grimes Consultancy, 29 Tradewinds Avenue, Paradise Point, Qld. 4216 
 
Introduction 
Australia is fortunate in not having some 
poultry diseases/infections that occur in other 
countries. Unlike many overseas countries, 
Australia being an isolated island continent, has 
no land borders with other countries, but 
Australia is on the migratory path of some wild 
bird species including waterfowl. Australia has 
strict government quarantine regulations and 
import requirements. Import of breeder 
hatching eggs has been permitted for some 
years, but only through quarantine stations with 
rigorous biosecurity precautions and disease 
testing. Import of inactivated vaccines is 
permitted. Imported live vaccines are produced 
from Australian SPF eggs, except by special 
authorisation which is currently occurring. 
Australia has very strict import requirements 
for chicken meat, table eggs and other poultry 
products. 
Economically Important Poultry 
Diseases/Infections in Australia 
Viral Diseases 
 Infectious Laryngotracheitis, Infectious 
Bronchitis, Avian Encephalomyelitis, Chicken 
Anaemia, Inclusion Body Hepatitis, Fowl Pox, 
Marek’s Disease, Leucosis/ Reticuloendo-
theliosis, Egg Drop Syndrome, Runting 
Stunting Syndromes, Proventriculitis, Inter-
mediate+ Infectious Bursal Disease Infections, 
Turkey Haemorrhagic Enteritis  
 
Bacterial Diseases 
 Necrotic Enteritis, Colibacillosis, Femoral 
Head Necrosis, Paratyphoid Salmonellosis, 
Fowl Cholera, Infectious Coryza, Enterococcus 
spp, Mycoplasma spp, Campylobacter 
Infections, Duck Infectious Serositis, 
Erysipelas, Avian Chlamydiosis 
 
Protozoan/Fungal Diseases 
 Coccidiosis, Blackhead, Aspergillosis, 
Mycotoxicosis 
 
Internal/External Parasites 
 Roundworms, Tapeworms, Mites, Lice  
 
Economically Important Poultry 
Diseases/Infections Not In 
Australia 
Viral Diseases 
 Gumboro Disease, Variant Infectious 
Bronchitis, Avian Pneumovirus Infections 
(Turkey Rhino-tracheitis, Swollen Head 
Syndrome of Chickens), Virulent Newcastle 
Disease, Avian Influenza, Duck Hepatitis, 
Duck Viral Enteritis 
 
Bacterial Diseases 
 Fowl Typhoid (Salmonella gallinarum), 
Virulent Salmonella enteritidis infections, 
Ornithobacterium Infections, Infectious Coryza 
Type B  
 
Examples of Vaccination Programs in Overseas Countries 
Breeders 
Age Vaccination Method 
Hatchery Marek’s (Rispens) Injection 
5 days Inactivated ND + Live IB Injection + Eyedrop 
6 days Live Salmonella Drinking Water 
7 days Coccidiosis Drinking Water 
9 days Live Reovirus Injection 
10 days Variant IB Spray 
14&20 days Live IBD Drinking Water 
21 days Variant IB + Live ND Spray 
38 days Live Salmonella; Live MG&MS Drinking Water; Eyedrop 
49 days Live IB + Live ND Spray 
70 days Live Avian Pneumovirus Eye Drop 
80 days ILT; Inactivated Fowl Cholera Eyedrop; Injection 
84 days Inactivated SE+ST; Live AE+TRT;  
Inactivated Fowl Cholera 
Injection 
90 days Live IB + Live ND Spray 
119 days Inactivated ND+IB+IBD+TRT; Inactivated 
Reovirus; Inactivated Infectious Coryza; 
Inactivated Fowl Cholera 
Injection 
35, 43& 51 wks Live IB (Variant at 43 wks); Live ND  
 
  
Broilers 
Age Vaccination Method 
In Ovo or Day Old   
- Hatchery 
Marek’s (HVT) Injection 
10 days Live IB (Variant) + Live ND DW 
12&18 days Live IBD DW 
20 days Live ND DW or Spray 
 
Gumboro Disease Caused By 
Very Virulent Infectious Bursal 
Disease (IBD) Virus 
Very virulent IBD occurs in all countries 
except Australia and NZ. Mortality of up to 
20% can occur in chickens over 3 weeks of age. 
Very virulent IBD virus also causes 
immunosuppression, as do other less virulent 
classical and variant IBD viruses. Control is by 
vaccination of broilers either once or twice, 
usually with intermediate+ vaccines. Maternal 
antibody (MAB) levels of broilers have to be 
taken into consideration to achieve effective 
vaccination. Intermediate+ vaccines can cause 
bursal damage if young broilers have low levels 
of MAB while high MAB interfere with 
effective vaccination. The Deventer formula is 
used in Europe and western Asia to estimate the 
age of vaccination and whether one or two 
vaccinations are required. The MAB titres of 5-
day old broilers from various breeding flocks 
are inserted into the Deventer calculator to 
decide when to vaccinate. Vector vaccines and 
antigen-antibody combination vaccines are 
available but are not widely used for control of 
Very Virulent IBD virus. The economic cost of 
the disease is due to mortality, immuno-
suppression, overall decreased productive 
performance and vaccination costs. 
Variant Infectious Bronchitis (IB) 
There is a number of IB virus variants reported 
around the world, often requiring new vaccines 
for control. The QX variant in Asia and Europe 
is one of the most economically important 
variant IB viruses. This IB virus variant causes 
a severe disease in broilers, breeders and layers. 
Infection in layers or breeders with QX variant 
in the first few weeks of life causes “false 
layers” with oviduct abnormalities. Affected 
birds do not lay eggs. The harmful affects of 
this variant is only discovered when the flock 
comes into lay and even then affected hens 
can’t be identified for culling as they appear to 
be normal birds. A special vaccine has been 
developed for prevention – but of course this 
adds cost to health programs. 
Virulent Newcastle Disease (ND) 
ND is still one of the most important economic 
diseases of poultry worldwide, despite 
vaccination being the main control measure. 
Vaccine reactions and inadequate control of 
virulent virus can contribute to late respiratory 
disease, particularly if there is immuno-
suppression due to IBD virus. Virulent ND 
occurred in Australia in commercial poultry in 
NSW and Victoria in 1998-2000 and was 
eradicated. The Australian V4 virus vaccine 
was used to assist eradication of locally-derived 
virulent ND in Australia. Will V4 vaccine be 
sufficient to control other strains of ND virus 
should these gain access to Australia and 
become endemic? 
Avian Influenza (Ai) 
Avian Influenza has become an important 
zoonotic disease of poultry in recent years, 
particularly because of the spread of H5N1 AI 
virus though Asia and Europe, but also because 
H7 AI virus also caused human disease. 
Australia has had five outbreaks of H7 AI since 
1976, all of which have been eradicated. 
Surveillance test evidence of H5 AI virus in 
wild birds in Australia in recent years is of 
epidemiological significance. Biosecurity 
procedures, particularly related to water fowl 
and their droppings, need to be actively 
managed. Vaccines have been approved for use 
in eradication programs in Australia as part of 
the national AI AUSVETPLAN. In addition to 
the poultry disease and human health 
consequences, outbreaks of AI can have 
devastating effects on poultry sales, at least in 
the short term. 
Salmonella enteritidis (Se) 
SE infection causes poultry disease, but more 
importantly is the major cause of salmonella 
food-poisoning of humans in many countries. 
SE PT26 occurs sporadically in Queensland, 
but has not caused disease in poultry or food-
poisoning outbreaks. The cost of endemic SE 
infection is due to lack of confidence in the 
safety of poultry products, particularly eggs, 
which can result in decreased sales and ongoing 
costs of control in poultry, mainly vaccination 
of breeders but also medication of broilers. 
Pneumovirus Infections 
Avian Metapneumonovirus infections occur in 
most countries except Australia and NZ causing 
Turkey Rhinotracheitis (TRT) and Swollen 
Head Syndrome (SHS) in chickens which are 
also called avian rhinotracheitis (ART). A 
severe respiratory disease and egg production 
drops in turkeys and chickens result. The 
respiratory disease in chickens can occur 
subsequent to infection with other respiratory 
viruses and can be complicated by bacteria 
such as E. coli. Control is by vaccination in 
breeders and turkeys, but vaccines are not often 
used in chickens because of the cost. This virus 
exacerbates the severity of poultry respiratory 
disease due to other causes with consequent 
mortality/morbidity and egg production losses 
which require costly vaccination programs to 
prevent. 
Summary 
So despite all precautions, Australia does have 
many economically important diseases which 
are usually well controlled but at a cost in 
vaccination, medication and biosecurity/ 
hygiene measures. A number of economically 
important diseases that occur in overseas 
countries do not occur in Australia. The 
occurrence of these diseases in Australia would 
increase the costs of poultry production in 
mortality, decreased productive performance 
and control measures and in some cases 
increase the risk to human health.  
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Summary  
In recent times, numerous outbreaks of 
Infectious Laryngotracheitis (ILT) have 
occurred in poultry in Australia, particularly in 
Victoria (VIC) and New South Wales (NSW). 
The objectives of this study were to identify the 
viral strains involved in the outbreaks over the 
last twelve months and to determine 
epidemiological relationships of isolated 
viruses. 
A combination of polymerase chain reaction 
(PCR) and restriction fragment length 
polymorphism (RFLP) analyses of ILTV genes 
was applied to identify genetic differences in 
the field and vaccine viruses. In previous 
studies conducted in our laboratory, these 
procedures had demonstrated nine RFLP 
classes (1 to 9) of Australian ILTV strains. 
Both Fort Dodge vaccine strains, A20 and SA2, 
belong to class 1 ILTV, whereas Class 7 is the 
Nobilis (Serva strain) ILT vaccine (Intervet Pty 
Ltd). The remaining classes of ILTV are field 
strains that have been identified and 
characterised in chronological order, as they 
were discovered.  
Class 9 was the most prevalent strain identified 
in the current study, with 32 cases from VIC 
and NSW in the past year. This strain was not 
found in any submissions from Queensland 
(QLD), South Australia (SA) or Western 
Australia (WA). In VIC, class 9 has displaced 
the previously endemic class 2 virus and spread 
from one side of Port Phillip Bay to the other. 
The series of outbreaks leading to this event 
suggests a lapse in biosecurity measures 
employed by staff and contractors travelling 
between farms.  
Class 2 was found in both Queensland and 
Victoria, but time of onset and previous records 
of existence of class 2 in these regions indicate 
that there is no significant link between the 
outbreaks. Class 3 was found only in game bird 
populations in NSW, QLD and WA and 
suggests a link with game bird transport 
between these states. 
In Australia, Infectious laryngotracheitis (ILT) 
causes substantial economic losses to both layer 
and broiler production companies. It is a highly 
contagious respiratory illness affecting 
gallinaceous birds and is associated with acute 
respiratory distress and reduced egg production 
(5). The virus is a member of the 
Herpesviridiae family, and like other herpes 
viruses can induce a state of latency in carrier 
birds (2,7,8). ILT can spread between farms in 
close vicinity to each other by fomites and/or 
aerosols (9).  
Embryo propagated vaccine ILTVs have 
previously been found accountable for field 
outbreaks in the US (3,11) so the ability to 
differentiate between ‘wild-type’ and vaccine 
strains of ILTV is of high importance to the 
Australian poultry industry. 
A range of studies have focused on the 
differentiation of ILTV genotypes across 
various countries by using restriction fragment 
length polymorphism (RFLP) patterns from 
endonuclease-digested PCR products (1,4,6) 
and this has recently become the most widely-
accepted method for genotyping ILTV isolates. 
Some research has been based on the 
differentiation of vaccine and field isolates 
using these patterns (1,4). More recently, a 
combination of RFLP patterns for a number of 
ILTV genes has been used for classification of 
ILTVs in Australia (10) and overseas (11). 
Application of this methodology on ILTVs 
isolated from different locations in Australia 
has resulted in identification of 9 different 
ILTV classes, with the SA2 and A20 vaccine 
strains classified as class 1 (10) and the Nobilis 
vaccine classified as class 7. The main purpose 
of the current study was to use this 
methodology to identify the ILTV classes 
responsible for the recent outbreaks of ILTV in 
Australia, to establish if there are any links 
between the outbreaks occurring in different 
states and to investigate if the vaccine strains 
may be linked to these outbreaks. 
 
Materials and Methods 
Viruses. The commercial ILTV vaccine strains 
SA2, A20 and Serva, along with ILTV field 
isolates collected over the last twelve months 
were used in this study (Table 1). All field 
isolates were isolated from the upper 
respiratory tract and/or conjunctiva of infected 
birds during outbreaks of ILT in Australia. All 
but three submissions for this study were made 
from commercial layer and broiler farms 
experiencing mortalities associated with ILT. 
Three submissions were from flocks of game 
birds (Table 2). A vaccine strain associated 
solely with morbidity, but not significant 
mortality, was not included in this study. A 
total number of 73 ILTV isolates were 
examined in this study, of which 49 were from 
VIC, 12 were from QLD, 9 were from NSW, 2 
were from SA and 1 was from WA.  
Extraction of viral DNA. DNA was extracted 
from infected CEK cell supernatant, 
commercial vaccines, or directly from swabs 
taken from infected trachea using a method 
described previously (10). Where insufficient 
amplification was achieved in PCR, virus 
isolates were propagated on chicken embryo 
kidney (CEK) cells using standard techniques 
(12). Scrapings of affected trachea and/or 
conjunctiva were diluted in cell culture medium 
and inoculated onto CEK cells. Once infected, 
CEK cells were frozen at -80ºC, thawed, 
centrifuged at 500 × g for 5 min, the 
supernatant removed and used for DNA 
extraction. The extracted DNA samples were 
used immediately or stored at -20ºC before use 
in the PCR.  
Polymerase chain reactions. Primers for the 
genes thymidine kinase (TK), infected cell 
protein 4 (ICP4) and infected cell protein 18.5 
(ICP18.5) were used in PCR as described 
previously (10) with some modifications. The 
ICP4 and ICP18.5 PCRs were carried out by 
subjecting the reactions to 94oC for one minute 
followed by 35 cycles of 94oC for 15 sec, 64oC 
for 45 sec and 68oC for 5.5 minutes, and a final 
extension of 68oC for 10 min. All PCRs were 
performed using Platinum Taq DNA 
polymerase high fidelity (Invitrogen, Carlsbad, 
CA). Control tubes containing distilled H2O, 
instead of extracted DNA were included as the 
negative control in all series of PCR. The PCR 
products were separated by electrophoresis in 
1% agarose gels, stained with GelRed 
(Biotium, Hayward, CA), and exposed to 
ultraviolet light for visualization using the 
Kodak Gel Logic 1500 Imaging System with 
Kodak Molecular Imaging Software (Version 
4.0.5, 2005) system. 
RFLP and staining. Ten µl volumes of PCR 
products were digested separately with the 
restriction endonucleases at 37ºC for 2 hr as 
described previously (10). The restriction 
endonuclease enzyme MspI was used for the 
TK gene products and HaeIII for the ICP4 and 
ICP18.5 PCR products. After digestion, the 
resultant DNA fragments were separated on a 
15% polyacrylamide gel. Restriction DNA 
fragments on polyacrylamide gels were 
visualized by staining with GelRed (Biotium, 
Hayward, CA), and subjected to digital imaging 
using the Kodak Gel Logic 1500 Imaging 
System with Kodak Molecular Imaging 
Software (Version 4.0.5, 2005) system. 
 
Results and Discussion 
A total number of 73 samples from VIC, QLD, 
NSW, SA and WA were referred to our 
laboratory for ILTV detection and strain 
identification in the last twelve months. These 
consisted of 49 submissions from VIC, 12 from 
QLD, 9 from NSW, 2 from SA and 1 from 
WA.  
Three cases were negative for ILTV and 
thirteen cases could not be typed due to virus 
degradation in the tissue submitted. Twelve 
cases were excluded, as they were associated 
with no or minor mortality due to a vaccine 
reaction (as confirmed by a detection of class 1 
or 7 genotype only). Of the two samples 
submitted from SA, one could not be typed due 
to virus degradation and the other contained a 
class 7 ILTV from a game bird and was 
therefore excluded. The remaining 45 
submissions made over the last year were from 
VIC, QLD, NSW and WA and are presented in 
table 2. 
From outbreaks associated with mortality, 
ILTV classes 2, 3, 8 and 9 were detected. The 
viruses were detected from a range of chicken 
flocks, including commercial broilers and 
layers and game birds.   
The majority of the viruses were identified as 
class 9 ILTV, most of which were submitted 
form Victorian farms. The first case of a class 9 
ILTV in Victoria detected by our laboratory 
was in November 2009, submitted from a layer 
farm on the outskirts of the Geelong region. 
The Intervet Nobilis vaccine was in use at this 
farm (personal communication with the 
company veterinarian). The next few months 
saw the class 9 virus appear in Melbourne’s 
outer western suburbs, central VIC, and then 
the Gippsland region. A total of 29 cases from 
VIC over the last year resulted in the 
identification of class 9 viruses. The movement 
of this virus strain, in a region previously 
endemic with class 2 ILTV, suggests a lapse in 
appropriate biosecurity measures associated 
with transport between farms (staff movements, 
feed trucks etc.).  
One case in May 2009 revealed a mixed 
infection of class 8 and 9 ILTV strains from a 
farm in the Sydney basin region. There were no 
submissions from NSW again until April 2010, 
when classes 8 and 9 were found individually.  
Class 2 was responsible for eight cases of ILT 
in both Queensland and Victoria. This class 
was the most prevalent in VIC during the 
outbreak period 2007/2008 and our laboratory 
records indicate that it had been in circulation 
in VIC as early as 1999 and QLD as early as 
2001. 
The presence of a class 3 ILTV isolate in game 
bird flocks in NSW, QLD and WA suggests a 
movement of the class 3 virus along with game-
bird transport. Records from our laboratory 
indicate that this genotype was in circulation in 
VIC and South Australia in 2004 (10). This 
emphasises that ILTV can also be a problem for 
“back-yard” and other small-scale poultry 
operations, which are not usually vaccinated 
and may act as a reservoir for the virus in the 
Australian poultry population, and vice-versa. 
 
Table 1. Classification of ILTV strains based on RFLP digestion pattern combinations 
PCR products    
TK  ICP4  ICP18.5  
Restriction Enzymes  
MspI  HaeIII  HaeIII   
RFLP PATTERNS CLASS Vaccine strain equivalent 
A A A 1 A20 / SA2 (Fort Dodge) 
B B B 2 - 
B A C 3 - 
B C C 4 - 
A A A   5* - 
B B C 6 - 
B D C 7 Serva (Intervet Nobilis) 
A D C 8 - 
A D A 9 - 
 
* PCR-RFLP of PCR product ORFB-TK using FokI, produced pattern B, which represents class 5.  
This is different for that produced by SA2 being pattern A, representing class 1  
 
Table 2. Field isolates typed in the current study over a twelve-month period. 
Month/Year Region Flock type 
ILTV 
Class 
Number 
 of cases 
May/2009 Sydney basin, NSW Broilers 8+9 1 
August/2009 Central NSW Game 3 1 
August/2009 Gold Coast Hinterland, QLD Broilers 2 1 
September/2009 Gold Coast Hinterland, QLD Broilers 2 2 
September/2009 South Eastern QLD Game 3 1 
October/2009 Gold Coast Hinterland, QLD Broilers 2 1 
November/2009 Geelong outskirts, VIC Layers 9 1 
November/2009 Geelong outskirts, VIC Broilers 9 2 
November/2009 Geelong outskirts, VIC Layers 9 1 
December/2009 Geelong outskirts, VIC Layers 9 1 
December/2009 Geelong outskirts, VIC Broilers 9 3 
January/2010 Outer-West Melbourne VIC Broilers 9 1 
January/2010 Central VIC Broilers 9 1 
January/2010 Gippsland, VIC Layers 2 1 
February/2010 Geelong outskirts, VIC Broilers 9 2 
February/2010 Gippsland, VIC Layers 2 1 
February/2010 Central VIC Layers 9 1 
February/2010 Gippsland, VIC Broilers 2 2 
March/2010 Gippsland, VIC Broilers 9 7 
March/2010 Perth, WA Game 3 1 
April/2010 Sydney basin, NSW Broilers 9 3 
April/2010 Gippsland, VIC Broilers 9 7 
April/2010 Geelong outskirts, VIC Broilers 9 1 
April/2010 Gippsland, VIC Layers 9 1 
April/2010 Sydney basin, NSW Broilers 8 1 
          Total 45 
 
In this study, genotyping of ILTV isolates by 
PCR-RFLP provided an understanding of the 
behaviour and spread of ILTV over the past 
year. The technique was adopted from a 
previous study (10) that screened a number of 
ILTV genes/genomic regions and restriction 
enzymes to select the most useful combination 
for ILTV typing. It needs to be highlighted that 
only a small number of genes are screened in 
this technique. In addition, RFLP can detect 
nucleotide sequence variations occurring only 
in the restriction sites used – there may be other 
variations in the genes/genomic regions that go 
undetected by this technique. Complete 
nucleotide sequences of the genes used in this 
study, or of other ILTV genes such as gM/UL9 
and gG/UL47 12 may be useful to confirm the 
relatedness of the classes designated in this 
study. Alternatively, complete genomic 
sequence analyses of ILTV isolates 
characterised in this study may reveal a full 
understanding of the relationship of the viral 
isolates. Information derived from full genome 
sequencing will also be useful for development 
of more rapid classification techniques such as 
real time PCR with high resolution melt curve 
analysis (HRM) or single strand conformation 
polymorphism (SSC) analyses.  
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The New 
To investigate host related differences in 
virulence, two strains of Pasteurella multocida 
capsular type F were compared. The strains had 
been isolated from chicken and rabbit, 
respectively, and both caused severe disease in 
the relevant original host. Multilocus sequence 
typing demonstrated that the two isolates were 
clonal – both belonging to ST9. Infection 
experiments in both homologous and 
heterologous hosts showed that the chicken 
strain affected rabbits severely and all animals 
died whereas in chicken less than half of the 
birds showed pathological abnormalities. The 
rabbit strain only caused mild symptoms in 
chicken although it was found highly virulent 
in rabbit. This is the first time host specific 
virulence reactions have been determined by 
capsular type F strains of P. multocida. 
The Old 
The demonstration that chicken isolates of the 
organism we now know as Pasteurella 
multocida can be highly virulent for rabbits was 
originally made by Louis Pasteur in the 1880s. 
In work performed in the walled gardens of the 
Pomery Champagne Estate (a concept we now 
called bio-secure containment), Pasteur and his 
nephew Lior showed that rabbits exposed by 
several routes (including on feed) to chicken 
isolates of P. multocida suffered high mortality.  
These experiments were performed as 
preliminary work intended to help Pasteur win 
the incredibly valuable prize of $10,000,000 
then on offer from the colonial governments of 
the eastern seaboard of Australia and New 
Zealand.  Pasteur then sent his nephew to 
Australia to claim the prize.  In a series of 
incidents that involved the Father of the 
Federation, the most famous actress of the time, 
rabid “anti-vaccination” forces, vested interests 
(who preferred their solutions of warren ripping 
and fencing), Pasteur was denied his claim.  
However, the Pasteur influence did leave a 
marked presence in Australia – the recognition 
of the presence of anthrax, the effective Pasteur 
anthrax vaccine, the new Australian produced 
anthrax vaccine (from John McGarvie-Smith 
who left the Pasteur team to set up his own 
vaccine company). The final connection was 
that the Queensland colonial government 
attempted to employ Lior as the founding 
director of the Institute now known as the 
Animal Research Institute.  Lior was too 
valuable for Pasteur and was ordered back to 
France.  The Queensland government employed 
a scientist who had spent some time in the 
Pasteur laboratory in Paris – C.J. Pound.  
Amongst the earliest work of C.J. Pound was 
the first confirmation that fowl cholera was 
present in chickens in Australia.  One of 
arguments against the use of P. multocida as a 
biological control agent was that the agent was 
not present in Australian chickens.  Pound was 
simply the first person to look for the organism. 
The confirmation of the presence of fowl 
cholera caused considerable controversy and 
several law suits that stained the otherwise 
glittering career of C.J. Pound. 
 
Everything Old is New Again 
Our work using MLST and PCR technologies 
has added some additional fine details (we have 
confirmed molecular evidence of the clonality 
of our isolates and that the isolates both belong 
to capsule type F).  In addition, we examined 
our isolates in both the original host and the 
alternative host.  However, our findings that the 
chicken isolate can indeed cause disease in 
rabbits is simply confirmation of knowledge 
acquired more than 100 years ago at the very 
dawn of the science of microbiology by Pasteur 
and his colleagues. 
Recommended Reading 
Stephen Dando-Collins (2008)  Pasteur’s 
Gambit – Loius Pasteur, the Australasian rabbit 
plague and a ten million dollar prize.  Vintage 
Books, Australia.   
 
   
Salmonella and Campylobacter Control in 
Processing 
Dr Margaret A. MacKenzie 
Inghams Enterprise Pty Limited 
Campylobacter and Salmonella are the two 
most frequently reported foodborne diseases, 
and chicken meat is an important food vehicle. 
Public health agencies worldwide are 
intensifying their efforts to lower foodborne 
illness by developing standards and control 
strategies aimed at eliminating or reducing 
these pathogens in the food chain, and setting 
goals for human salmonellosis and 
campylobacteriosis. 
On farm control strategies based on biosecurity 
will continue to reduce Salmonella and 
Campylobacter incidence, however at present 
complete eradication of Salmonella and 
Campylobacter is unrealistic. 
Risk assessments indicate that high levels of 
pathogens on chicken meat constitute the major 
public health risks. A reduction in the levels of 
Salmonella and Campylobacter on chicken 
would be expected to lead to a reduction in the 
number of human cases. 
The number and prevalence of Salmonella and 
Campylobacter on poultry entering the 
processing plant varies greatly depending on 
the time of year, region, flock, environment and 
preharvest management. Recent Australian 
research showed Salmonella levels ranging 
from log 2.8 – 4.9 and Campylobacter from log 
8 – 8.5 on incoming carcases. 
The levels on carcases leaving the plant can 
increase or decrease depending on the 
effectiveness of process control strategies in the 
processing plant. 
Poor process control will increase both the 
prevalence and numbers of Salmonella and 
Campylobacter on carcases due to 
multiplication and cross cross-contamination. 
The implementation and adherence to pathogen 
reduction interventions based on HACCP 
principles during processing can effectively 
lower the levels of Salmonella and 
Campylobacter to target levels of < log 2.0 for 
Salmonella and < log 3.78 for Campylobacter 
on carcases exiting the chiller. At these levels 
risk assessments indicate there would be a 
significant reduction in human illness from 
chicken consumption. 
In the 2009 Australian industry baseline survey 
of carcases ex chill, prevalence of Salmonella 
was 18% (8% non-sofia isolates), overall 
average count was 2.09 log MPN per carcase 
and range 1.18 – 2.88 log MPN per carcase, 
prevalence of Campylobacter was 95%, overall 
average count was log 3.93 per carcase, and 
range 2.52 – 7.4 log per carcase. Overall, 89% 
of plants achieved the Salmonella target of < 
log 2.0 and 67% achieved the Campylobacter 
target of < log 3.78. 
Critical control points in the processing plant 
for effective pathogen reduction include plant 
hygiene and sanitation feed withdrawal time (8 
to 12 hours), prescald brushes and sprays, scald 
tank hygiene (multiple counterflow tanks, 
adequate overflow rates, scald treatments), 
evisceration operation and adjustment to 
prevent faecal leakage, multiple washes and 
sprays, immersion chill disinfection (5ppm free 
available chlorine, pH 6.0 – 6.5, adequate 
overflow rate, temperature < 4°C, counterflow 
current, meat : water ratio, prechill immersion 
or spray disinfection, airchill sprays, postchill 
dips and sprays and postchill hygiene and 
temperature control (< 4°C). 
Monitoring of Salmonella and Campylobacter 
on carcases ex chill should be used to verify the 
effectiveness of process control during 
processing and compliance with industry or 
regulatory targets. 
Processing plant pathogen intervention 
strategies, operated correctly, can achieve a 
significant reduction in Salmonella and 
Campylobacter levels on broiler carcases which 
is likely to reduce the incidence of 
Salmonellosis and Campylobacteriosis 
foodborne illness in humans. 
SNP Types of Campylobacter jejuni 
Isolated from Different Hosts 
Jan-Maree Hewitson1, Lesley Duffy2, Narelle Fegan2, Rowland 
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Summary 
In this study we applied Single Nucleotide 
Polymorphism (SNP) typing to 577 
Campylobacter jejuni isolates from different 
host species, including chickens, feedlot cattle, 
dairy cattle, dogs, cats and humans. We found 
that SNP typing was an effective method for 
genotyping C. jejuni. The results show that 
some Campylobacter genotypes do show host 
specificity, which should be considered when 
investigating outbreaks of campylobacteriosis 
in humans. The SNP typing results clearly 
show that there are sources other than poultry 
meat associated with human 
campylobacteriosis.  
Introduction 
Campylobacter is the major cause of human 
gastrointestinal illness in Australia, with rates 
of infection approximately double those for 
Salmonella spp. each year. While poultry are a 
significant source of these infections, there is a 
considerable body of evidence that there are 
other sources, for example raw milk and pets 
(1, 2). Some types of C. jejuni/coli appear host 
specific (meaning that some types occur only in 
chickens) while other types can be found in 
multiple hosts (e.g. in both chickens and 
humans). There is a general agreement that the 
definitive method for typing C. jejuni/coli is 
Multilocus Sequence Typing (MLST) (3-5). 
The high cost of MLST, caused by the 
requirement to sequence around 500 base pairs 
in each of seven genes, has recently been 
overcome by the use of a combination of 
kinetic PCR and interrogative data analysis that 
provides the power of conventional MLST but 
at a much lower cost and with a more rapid 
response time. This new technology is called 
Single Nucleotide Polymorphism (SNP) 
analysis.   
The objective of this study was to apply the 
technique of SNP analysis for typing C. jejuni 
to both poultry and non-poultry isolates.  To 
achieve this we extended the current Agri-
Science Queensland Campylobacter collection 
to include poultry isolates from other research 
groups and industry and we obtained non-
poultry isolates from sources such as cattle, 
pets and humans. We were then able to 
compare and contrast the SNP types of the 
poultry C. jejuni with the non-poultry types. 
Materials and Methods 
In our study SNP typing as previously outlined 
(6) was applied to 577 C. jejuni isolates. The 
isolates consisted of: 
• 32 Chicken faecal/caecal isolates from 
epidemiological studies (1999-2003) 
• 36 Chicken Factory isolates (2008) 
• 76 Chicken Factory isolates (2005-2006) 
• 77 Chicken caecal isolates collected from 
a national survey (2003-2004) 
• 93 Dairy Cattle isolates (2006-2008) 
• 123 Feedlot Cattle isolates (2006-2008) 
• 39 Dog and eight Cat isolates (2006-2008) 
• 46 Human isolates (2000) 
• 47 Human isolates (2008). 
Results  
In our study we applied SNP typing to 577 C. 
jejuni isolates from different host species.  The 
577 isolates were grouped into 39 different 
SNP types.  Our results show that some 
genotypes are associated with multiple host 
species whereas other genotypes are 
predominantly associated with limited host 
species. As an example, SNP type 44 was a 
genotype found only in humans, dogs and cats. 
SNP typing has also shown subtle differences 
in genotype distribution. SNP type 5 was 
associated with dairy cattle while SNP type 13 
was associated with feedlot cattle.  
Discussion 
SNP typing is an effective method for 
genotyping C. jejuni, including the capacity to 
recognise host associations. Some 
Campylobacter genotypes do show host 
specificity, which should be considered when 
investigating outbreaks of campylobacteriosis 
in humans. The genotyping results clearly show 
that there are sources other than poultry meat 
associated with human campylobacteriosis. In 
particular, pets need to be considered as a 
source of C. jejuni for humans. Some 
preliminary data from our studies indicates that 
regional and company influences may play a 
role in the genotype distribution of 
Campylobacter isolates in poultry and we are 
currently investigating this further. 
Overall, SNP typing has been shown to be a 
convenient first line tool for screening C. jejuni 
isolates. It is user friendly, easily transportable 
between research groups, is relatively cheap 
and has the advantage that it is directly linked 
to MLST. Unlike PFGE, SNP typing lends 
itself to robotics for sample preparation and 
assay set up. We would recommend SNP 
typing as a front line typing method when 
investigating outbreaks of campylobacteriosis 
or when looking for host associations with 
particular genotypes of C. jejuni. 
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Evaluation of Residues in Eggs after 
Treatment of Pullets with Toltrazuril, 
Sulfadimidine or Amoxycillin. 
Timothy Wilson1, Angus Crossan2 and Peter Scott1  
Background 
There is a limited number of therapeutics 
available in Australia for treating disease in 
layer pullets. In fact without the provision of 
specific egg residue data to the regulator any 
product registered for chickens must have the 
disclaimer; “Not to be used in poultry 
producing eggs for human consumption or 
which will ever produce eggs for human 
consumption”. The absence of adequate 
antibiotic classes has welfare implications in 
limiting the ability to teat clinically sick birds 
under particular circumstances as well as 
impact lifetime productivity. 
In 2004 the APVMA (Australian Pesticides and 
Veterinary Medicines Authority) granted 
AECL (Australian Egg Corp Ltd) permits for 
the use of 3 groups of antibiotics in 
replacement pullets (both layers and breeders) 
pending the outcome of egg residue data to 
allow the establishment of suitable withholding 
periods to allow further use in a manner shown 
to be safe to the public. Scolexia Avian and 
Animal Health Consultancy was contracted by 
AECL to undertake the study reported here. 
Experimental design 
The hypothesis examined the MRLs and 
withholding periods allowed under the 
APVMA permits as follows: 
For each of the therapeutics (“y”): 
1. H0 Egg [Antibiotic residue] ≤ MRL y at the 
end of the withholding period y 
2. H1 Egg [Antibiotic residue] > MRL y at the 
end of the withholding period y 
The temporary MRLs and withholding periods 
in eggs for each antibiotic are listed below; 
• toltrazuril     0.05 mg/kg 6 weeks 
• sulfadimidine 0.01 mg/kg  2 weeks 
• amoxycillin    0.01 mg/kg  1 week 
In addition the rate of decline of residues in all 
eggs was logged and the concentration of the 
residue in first eggs was described with respect 
to time since treatment. 
Materials and Methods 
Treatment groups were selected after 
discussion with the APVMA. For the 
amoxycillin and toltrazuril groups one 
commercial product was selected as 
representative. For the sulphonamide group, 
sulfadimidine was selected as representative of 
the group for two reasons; it has the lowest 
MRL of the group and is contained in products 
with the highest dose rates. Treatments were 
administered as described in table 1 below.  
As toltrazuril may be used on more than one 
occasion, treatments (each for 2 days) were 
given one week apart. Treatments for 
amoxycillin and sulfadimidine were each given 
daily for 5 days. Hisex pullets were transferred 
to the cage layer trial facility (Scolexia Animal 
Research Facility (SCARF) at 12 weeks of age. 
They were fed a commercial bagged ration that 
contained no antibiotics. 
Table 1: Treatment groups 
Group Treatment Birds per group Dose rate (active)  
mg / kg BWt / day 
A Control 33  
B Baycox® Coccidiocide Solution 
(Toltrazuril) 
30 7 
C CCD Sulfadimidine sodium soluble 
Sulfadimidine sodium 
30 45.6 
D AFS Amoxycillin soluble  
Amoxycillin trihydrate powder 
Amoxycillin trihydrate 
30 20 
 
The treatments were administered such that the 
withholding periods (listed above) for each 
group ended on the same day. The point of lay 
was managed by a lighting program which 
slightly delayed the onset of lay to ensure most 
“first eggs” were laid around the end of the 
withholding period. Each treatment was mixed 
in water and administered orally. Prior to 
treatment birds were weighed. For 
sulfadimidine and amoxycillin treatments the 
birds were re-weighed on the forth day of 
treatment. The birds were weighted on the first 
day of each toltrazuril treatment. Doses for 
each bird were calculated according to 
bodyweight for that bird 
Table 2 lists the residue definitions and 
anolytes that were examined. The analysis was 
conducted using HPLC/MS/MS by Agrisearch 
Analytical (Victoria Rd, Roselle, NSW). Egg 
shell was not included in the analysis which 
analysed yolk and white combined. 
Table 2: APVMA MRL Standard Anolytes to be determined. 
Antibiotic Residue definition LOQ 
(mg/kg) 
Toltrazuril Sum of toltrazuril, its sulfoxide and sulfone, expressed as toltrazuril. 0.05 
Amoxycillin Inhibited substance, identified as amoxycillin 0.01 
Sulfadimidine The parent compound per se. 0.01 
   
Results 
Egg-laying began in one bird on the 14th of 
November 2010 and by the 17th of November at 
least one bird from each group had begun to 
lay. Over a third of the treated birds (33/90) 
laid their first egg three days either side of the 
end of the withholding period. Results of “first  
eggs” as well as serial results (approximately 
every two days) from 5 chickens are presented 
for each group.  
In all group B assays toltrazuril and toltrazuril 
sulfoxide residues (if present) were below the 
limit of detection. Quantifiable levels of 
toltrazuril sulfone were found in some of the 
treated eggs. Table 3 lists the results. 
 
  
Days after  
last treatment 
Bird 
No 
Total 
Toltrazuril 
(mg/kg) 
Days after last 
treatment Bird No 
Total 
Toltrazuril 
(mg/kg) 
31 29 <0.073 44 10 <0.02 
34 27 <0.074 45 6 <LOD 
36 1 <0.068 46 2 <0.019 
36 19 <0.043 46 3 <0.016 
37 8 <0.033 46 18 <LOD 
37 12 <LOD1 47 15 <LOD 
37 13 <0.019 47 17 <0.021 
37 23 <0.017 48 5 <0.015 
40 14 <LOD 48 11 <0.021 
42 7 <0.028 48 21 <LOD 
42 20 <0.016 49 4 <LOD 
42 24 <0.02 53 16 <LOD 
42 26 <0.019 55 22 <LOD 
43 28 <0.019 56 25 <0.017 
Table 3: Concentration of total Toltrazuril in first eggs since treatment  
1 LOD = Limit of detection 
The temporary MRL for total toltrazuril in eggs 
examined under the hypothesis was 0.05 mg/kg 
with a 6 week egg withholding period. The last 
day that a first egg was over the MRL was day 
36 after treatment. By day 38 the average 
residue in eggs tested serially from the same 
five chickens were under the MRL. The 
concentration of toltrazuril residues in first eggs 
on the forty third day after treatment or 
thereafter was never greater than 0.021 mg/kg 
and on the 42nd day after treatment no egg had a 
value of higher than 0.036 mg/kg. The average 
of all eggs tested 42 days after treatment was 
0.018 mg/kg total toltrazuril. Therefore the null 
hypothesis that the concentration of toltrazuril 
in eggs after a withholding period of 42 days is 
under the MRL was supported. 
This study demonstrates that multiple uses of 
the anticoccidial product toltrazuril in chicken 
pullets will not result in residues in eggs over 
the MRL of 0.05 mg / kg total toltrazuril if a 
withholding period of 42 days (6 weeks) after 
treatment is observed.  
Sulfadimidine residues in the first eggs from 
pullets in group C are listed below in table 4  
Bird no DALT1 
Sulfadimidine  
(mg/kg) Bird no DALT1 
Sulfadimidine  
(mg/kg) 
51 4 0.36 37 13 <LOD 
48 7 0.1 54 13 <LOD 
52 7 0.081 56 13 <LOD 
58 7 0.011 34 14 <LOD 
31 9 <LOD 41 14 <LOD 
39 9 <LOD 57 14 <LOD 
45 9 <LOD 47 15 <LOD 
33 10 <LOD 55 15 <LOD 
42 10 <LOD 35 16 <LOD 
44 10 <LOD 46 16 <LOD 
33 11 <LOD 38 19 <LOD 
40 11 <LOD 50 19 <LOD 
Table 4: Sulfadimidine residue in first eggs from pullets treated with sulfadimidine sodium 
Nb: LOD = Limit of detection 
1 DALT  = days after last treatment 
The temporary MRL in eggs examined under 
the hypothesis was 0.01 mg/kg, with a 
temporary withholding period of 2 weeks. All 
first eggs tested were under the temporary 
MRL by 9 days after the last treatment and all 
eggs collected from 5 hens serially were under 
the temporary MRL by 10 days after treatment. 
In both groups the sulfadimidine residues in 
eggs were under the limit of detection by day 
10. The null hypothesis that the sulfadimidine 
residues in eggs from pullets treated with 
sulfadimidine would be under the temporary 
MRL by the end of the withholding period of 
14 days is supported by the data. 
Quantifiable residues of amoxycillin were 
found in some of the eggs from group D birds. 
Amoxycillin residues in first eggs are listed 
below in table 5. 
Table 5: Amoxycillin levels in first eggs from pullets treated with Amoxycillin 
Bird 
number 
Days after  
last treatment 
Amoxycillin  
(mg/kg) 
Bird 
number 
Days after  
last treatment 
Amoxycillin  
(mg/kg) 
67 -2 0.013 75 5 <LOD 
73 -1 0.009 86 5 <LOD 
64 0 0.028 61 6 <LOD 
81 1 0.016 71 6 <LOD 
83 1 0.006 79 6 <LOD 
90 1 0.02 66 7 <LOD 
62 2 0.008 70 7 <LOD 
63 2 0.013 84 7 <LOD 
77 4 <LOD 65 8 <LOD 
80 4 <LOD 68 8 <LOD 
82 4 <LOD 74 8 <LOD 
85 4 <LOD    
 
Nb: some values listed were below the limit of quantification    LOD = Limit of detection 
 
 
The temporary MRL examined under the 
hypothesis was 0.01mg/kg with a temporary 
withholding period of 7 days. No first eggs 
were collected on day 3 after the end of 
treatment and on day 4 and thereafter all first 
eggs had no detectable amoxycillin residues. 
On day three after the end of treatment average 
amoxycillin residues in eggs from five birds 
were on average 0.0033 mg/kg and from day 
four and onwards no amoxycillin residues were 
detected in the eggs from any of the five 
pullets. The null hypothesis that residues of 
amoxycillin in eggs from treated hens would be 
under the MRL after a withholding period of 7 
days is supported by the data in this study. 
60 12 <LOD    
The results of the study for each of the three 
anolytes, toltrazuril, sulfadimidine and 
amoxycillin support the null hypotheses that 
when treated at the maximum dose rate eggs 
from birds treated with these antimicrobials 
will be under the MRLs examined if the 
prescribed withholding periods for eggs are 
observed.  
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Introduction 
 
This paper seeks to set out the broad focus of 
the two organisations associated with the 
funding of poultry research in Australia.  The 
focus of the paper is to set out the general 
features of the research programs of the two 
bodies – the Poultry CRC and the Chicken 
Meat program within the Rural Industries 
Research and Development Corporation 
(RIRDC)  
The CRC 
 
The new Poultry CRC officially came into life 
on January 1st 2010.  The CRC has three 
integrated programs of research.  Program 1 is 
entitled Health and Welfare; Program 2 is 
entitled Nutrition and Environment while 
Program 3 is entitled Safe and Quality Food 
Production.  At the time of writing, the formal 
decisions on which particular sub-projects (the 
CRC equivalent of an RIRDC Project) will be 
funded have not been made.  However, the 
formal documentation for the CRC does 
provide broad outlines of the outputs expected 
from the three Programs.  These outputs 
include:- 
 
• Novel vaccines for significant diseases 
Program 1 
• Novel diagnostic tests 
• Methods for sex determination in 
poultry 
• Bacterial and viral vectors tested for 
delivery of NetB vaccine 
• Novel anti-viral and anti-parasitic 
therapeutics 
• New evidence-based welfare methods 
 
• A set of nutritional tools to maintain 
good gut health in poultry 
Program 2 
• New feed formulations based on net 
energy of common Australian feed 
ingredients 
• Commercialisation of odour and 
greenhouse gas (GHG) sensing systems 
and mitigation processes 
  
• Rapid detection methods for 
Campylobacter in poultry 
Program 3 
• Management options that allow industry 
to adopt targeted, operation specific 
food safety programs to reduce 
Campylobacter levels in meat chickens 
• Improvements in egg quality and safety 
 
While no longer a separate program, education 
is a strong theme within the CRC.  There are 
plans for an active post-graduate program.  As 
well, direct industry associated education 
activities (VET, industry placements, 
internships) will have a high priority.  
The RIRDC 
 
The RIRDC has, at the time of writing, a total 
of 38 projects that are listed as current.  The 
projects are at varying stages of the project 
cycle – from just commencing to awaiting 
approval of the final report.  An overview of 
the broad areas of activities of these projects is 
in Table 1:- 
 
Broad Area Project Topics 
Conference 
Sponsorship 
Conference Travel 
(Four projects) 
• AI 
• Campylobacter, 
• PIX 
Infectious Diseases 
(Eight Projects) 
• Chlamydophila 
• Pasteurella multocida 
• AI 
• IB 
• IBD 
• ILT 
• MD 
Food Safety 
(Eight Projects) 
 
• Campylobacter - abattoir surveys/workshops, effect of litter re-use, phages to 
control levels in live birds, rapid detection, typing, vaccines 
• Salmonella - abattoir surveys/workshops, effect of litter re-use, typing 
Environment 
(Eight Projects) 
 
• Litter – broad-acre usage; biochar workshop;  nutrient run-off, alternative 
fertiliser 
• Lifecycle Assessment 
• Mass Mortality Composting 
• Waste into Energy 
• Artificial Olfaction 
Nutrition 
(Four projects) 
• Heat stress 
• Assessing available energy in grains 
• Steam pelleting of sorghum 
• New triticale lines 
Others 
(Six projects) 
• Workboot Series 
• Biosecurity/Food Safety DVDs 
• Darkling Beetles 
• Nutrient composition of chickens 
• Human resources audits 
• Program Evaluation 
 
Table 1: Overview of the broad areas of activities of the RIRDC 
 
 
Roles of RIRDC and CRC 
  
The Australian poultry industry is in a unique 
position in the world.  The industry has 
available two significant mechanisms of 
industry focussed, government supported 
research programs.  These two programs have 
significant overlap in terms of research service 
providers as well as those making the decisions 
about which particular topics should be funded.  
This results in a co-ordinated research 
programs with each funding arm being aware 
of the activities and focus of the other body. A 
good example of the co-ordination is in the 
food safety area where the CRC and the 
RIRDC have agreed that the CRC program 
should focus attention to on-farm interventions 
as the RIRDC structure is more suited for in-
plant interventions.  
The CRC has a mandate to work as a “family” 
organisation.  All sub-projects are led from 
within the “family” and all work – where 
possible – is undertaken within the family.  The 
CRC has a mandate to undertake a percentage 
of blue sky research (with the recognition of the 
NetB toxin of Clostridium perfringens being an 
outstanding example of blue sky research that 
has significant practical applications.  A similar 
breakthrough example is the work of the CRC 
on sex determination – a project which has 
major economic and welfare implications.  The 
blue sky research of the CRC is balanced by 
practical industry focussed work – with the 
suite of rapid molecular tests available from the 
University of Melbourne being a good example 
of this. 
The RIRDC has a broader mandate and 
provides the industry with access to all 
interested, capable and relevant research 
organisations.  The strong industry linkages of 
the RIRDC are well suited to those research 
programs where practical, applied research with 
a short horizon is required.  The RIRDC has 
been very active recently in education and 
industry focussed workshops.  The Workboot 
Book on the meat chicken industry (also 
associated with the CRC) has proven a very 
effective communication tool (it is shortly 
expected to reach the New York Times best 
seller list!!).  A particularly successful recent 
activity has been a series of workshops 
focussed on interventions in the processing 
plants to reduce levels of Salmonella and 
Campylobacter. 
Overall, the two research mechanisms that 
support the chicken meat industry are quite 
distinct but – at the same time – quite co-
ordinated.  The bodies differ in their focus and 
their mandates.  The Australian poultry 
industry will gain substantial benefits from both 
organisations over the next five years.        
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The outcomes of an Australian Poultry CRC 
project have facilitated the establishment of a 
core diagnostic centre for poultry diseases in 
Australia. This laboratory can provide rapid 
and reliable world-class diagnostic services for 
the Australian poultry industry. Examples of 
the diagnostic assays are overnight diagnosis 
and strain identification for infectious 
bronchitis virus, Chlamydophila psittaci, M. 
gallisepticum, fowl adenoviruses, etc. This will 
enable the core centre to rapidly solve, at a low 
cost, epidemiological questions related to major 
poultry diseases in Australia. Twenty-seven 
diagnostic assays for different pathogens are 
available to the Australian Poultry Industry as 
follows overleaf: 
: 
  
 DIAGNOSTIC ASSAYS 
Test Result 
Avian Encephalomyelitis Virus (AEV) rt-PCR detection 
Avian Leukosis Virus (ALV) rt-PCR detection 
Avian Leukosis Virus Subgroup-J (ALV-J) rt-PCR detection 
Avian Nephritis Virus (ANV) PCR detection 
Avibacterium paragallinarum PCR detection 
Chicken Anaemia Virus (CAV) PCR detection 
Chlamydia sp. PCR detection 
Chlamydia sp. PCR-HRM detection and species ID 
Escherichia coli multiplex PCR detection and virulent strain ID 
Egg Drop Syndrome (EDS) PCR detection 
Fowl Adenovirus (Inclusion Body Hepatitis) PCR HRM curve analysis detection and strain ID 
Fowl/pigeon POX PCR detection 
Infectious Bursal Disease Virus (IBDV) rt-PCR-HRM detection and strain ID 
Infectious Bronchitis Virus rt-PCR-HRM detection and strain ID 
Infectious Bronchitis Virus Subgroup-1 PCR detection and strain ID 
Infectious Laryngotracheitis virus PCR detection 
Infectious Laryngotracheitis virus -PCR-RFLP detection and strain ID 
Marek’s Disease Virus PCR detection 
Mycoplasma gallisepticum PCR detection 
Mycoplasma gallisepticum PCR-HRM detection and strain ID 
Mycoplasma anatis PCR detection 
Mycoplasma meleagridis PCR detection 
Mycoplasma synoviae PCR detection 
Mycoplasma synoviae PCR-HRM detection and strain ID 
Pasteurella multocida PCR detection 
Avian Reovirus rt-PCR detection 
Reticuloendotheliosis virus PCR detection 
rt: reverse transcriptase, HRM: high-resolution melt, RFLP: restriction fragment length polymorphism 
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INTRODUCTION 
Inclusion body hepatitis (IBH) in chickens 
emerged in 1963 in the U.S.A. (1) and was first 
reported in Australia in 1974 (2).   The disease 
now has worldwide distribution in domestic 
avian species of all ages, with indications that 
incidents of the disease are increasing (3).  IBH 
can be characterised by sudden onset of 
mortality, usually between 3-7 weeks of age 
and enlarged mottled and friable livers (4).  In 
Australia IBH outbreaks have occurred in 
chickens less than 3 weeks of age (5).  The 
economic significance of FAdVs is unclear due 
to the variability in their disease association (3), 
however with peak mortalities as high as 30% 
(4), adequate control measures to reduce the 
incidence of IBH are imperative. 
FAdVs are readily transmitted horizontally via 
the oral-faecal route, due to high viral titres 
present in the faeces.  Vertical transmission of 
FAdVs and the establishment of latent infection 
has been shown to occur in chickens (6), and 
may remain undetected for at least one 
generation in a specific-pathogen-free (SPF) 
flock (7).  Immunosuppression resulting from 
infection with infectious bursal disease virus 
(IBDV) or chicken anaemia virus (CAV) have 
long been suspected of facilitating outbreaks of 
IBH (8, 9).  There is however, mounting 
evidence that IBH can be a primary disease of 
poultry (4, 5, 10-12). 
Previous studies of IBH outbreaks in Australia 
identified serotypes in species groups A 
(FAdV-1) and E (FAdV-6, 7 and 8) (5), with 
FAdV-8 exhibiting the highest virulence.  IBH 
was a significant problem in broiler chickens 
from the 1970’s through early 1990’s, with 
FAdV serotype 8 (now divided into 8a and 8b) 
isolated from the majority of outbreaks (12, 
13).  Serotype 2/12 (now serotypes 2 and 11) 
was reported in a 12 week old SPF cockerel 
(14).    
The Australian FAdV vaccine (Intervet, Pty 
Ltd.) was developed in 1989 from a non-
attenuated FAdV-8b strain (Esurient) and 
aimed to control IBH by means of protecting 
broiler flocks via maternal antibodies from 
vaccinated parent flocks.  The vaccine is known 
to prevent IBH in progeny birds aged mainly 7-
21 days, but it is unlikely that it prevents IBH 
after three weeks of age (personal 
communications with Tom Grimes).  In recent 
years there have been sporadic occurrences of 
IBH in Australian broilers.  Investigation of the 
re-emerging problem of IBH has been 
undertaken to identify the FAdV serotype(s) 
involved, and to establish if FAdV was the sole 
causative agent in the disease in the absence of 
immunosuppression caused by IBDV or CAV. 
 
 
RESULTS AND DISCUSSION 
Identification of the serotype(s) involved in 
IBH outbreaks is very useful for 
epidemiological tracing and is of critical 
importance where vaccination is to be used for 
control of disease (3).  Typing of strains 
conventionally by virus microneutralisation is 
cumbersome, requiring reference materials, and 
results often require extensive interpretation 
(11).  Tests using PCR together with DNA 
sequencing (15) and/or restriction enzyme 
analysis (16, 17) have been used for 
comparatively faster FAdV typing, but the 
process is lengthy and results can be difficult to 
interpret.  Recently, HRM curve analysis of 
PCR amplicons of the Loop 1 (L1) region of 
the hexon gene was used to accurately 
genotype reference strains from each of the 
twelve FAdV serotypes (18), and has since 
been introduced as a commercially available 
test at the APCAH diagnostic laboratory at The 
University of Melbourne for routine typing of 
field specimens.   
Serological screening of parent flocks and 
progenies for type-specific antibodies may 
elucidate the presence and distribution of 
different FAdVs, and the efficacy of current 
vaccination strategies.  Serum 
microneutralisaiton is an option, however this 
is costly and time consuming to perform as a 
routine diagnostic test.  Attempts to express a 
protein suitable for use in a type-specific 
ELISA for rapid and affordable serological 
screening have so far been unsuccessful.  This 
may have been due to incompatibility of the 
expression system used with the FAdV protein 
and/or the presence of hydrophobic regions in 
the protein.  Codon optimisation or a different 
expression system may be required for 
successful expression of the FAdV hexon 
proteins, for the development of a type-specific 
ELISA. 
Since 2000, 42 cases from commercial poultry 
farms located in Victoria, New South Wales 
and Queensland have been submitted to the 
APCAH laboratory.  Nine of these cases were 
confirmed as IBH by histopathology alone.  
Thirty-three cases were screened by PCR/HRM 
genotyping, with FAdV-8b identified in 13 
cases and FAdV-11 identified in 19 cases.  In 
one case FAdV-1 was also identified, in the 
absence of clinical signs or histopathological 
lesions relevant to IBH in this individual bird.  
In the five cases tested for CAV and IBDV, 
neither virus was detected in association with 
an IBH outbreak.  Evidence suggested 
sufficient antibodies against CAV and IBD 
were present in parent flocks and there was no 
indication that immunosuppression caused by 
these viruses was present in any of these cases. 
The Australian FAdV vaccine is registered to 
be administered at 18-20 weeks of age by 
eyedropper to 100% of the flock at the rate of 
one label dose per bird.  However, the 
vaccination strategy used by the five poultry 
companies for broiler parent flocks varied.  All 
parent flocks were vaccinated once, twice or 
three times, usually via the drinking water, at 
between 9 and 18 weeks of age, with the flock 
receiving 10, 20, 50 or 100% of the 
recommended dose on each occasion.  Where 
100% vaccination was used, only FAdV-11 
was detected in IBH cases in progenies.  No 
relationship could be drawn between 
geographical location and the FAdV serotype 
identified from outbreaks of IBH, nor was there 
any correlation between FAdV serotype and 
rate of mortality. 
Chickens from a wide range of ages, 9 to 37 
days, were affected.  All bar one of the cases 
from which FAdV-8b was isolated were from 
broilers over 17 days of age.  It may be 
postulated that these were the result of 
horizontal infection, and a lack of sufficient 
protective maternal antibodies against FAdV-
8b.  However, FAdV vaccination of parent 
flocks in the absence of uniform or high 
antibody may result in vertical transmission of 
the vaccine virus to the progeny.  
In all of the cases affecting birds under 16 days 
of age, except one, the FAdV-11 field strain 
was isolated.  These cases may be a result of 
vertical transmission of the virus from the 
parent flock.  However, it is also possible that 
they resulted from horizontal infection, 
particularly since cross-protection may not 
exist between the Australian vaccine and this 
field strain, as these viruses belong to different 
species groups.  While cross-protection may 
exist between serotypes belonging to the same 
species group, this is unlikely to be the case for 
serotypes of different species (3). 
These investigations of recent outbreaks of IBH 
in Australian broiler flocks provide evidence 
that it is a primary disease resulting from two 
alternative FAdV strains from different species 
groups.  The route of infection, horizontal or 
vertical, is unclear.  Consequently, protection 
against outbreaks of IBH in Australian broiler 
flocks may require the use of an additional 
FAdV-11 vaccine, or a single dual serotype 
FAdV vaccine, and should be further 
investigated.  The application of a killed 
vaccine, which is common practice in other 
countries where IBH is prevalent, or 
attenuation of live viruses for use in vaccines, 
should also be considered. 
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Summary 
Fowlpox virus has economic importance, 
particularly in developing countries. Research 
was undertaken to see if homeopathic 
preparations would have significant effects on 
bird   immune and production response to 
Fowlpox vaccination, and if the use of 
homeopathic medicines would be worth further 
research. Responses to medication with 
homeopathic Fowlpox Isode and homeopathic 
Thuja occidentalis were examined in healthy 
Lohmann brown laying hens before and after 
Fowlpox vaccination. After layer vaccination 
hens showed significant (P<0.05) body weight 
change in the Fowlpox Isode treated group 
compared to controls, and increased vaccine 
site swelling in the Thuja occidentalis treated 
group. Therefore homeopathic preparations 
altered vaccine response in healthy Lohmann 
Brown hens, and further research is justified.   
Key words: Fowlpox vaccination, Fowlpox 
Isode, Immune, Thuja occidentalis, 
Homeopathic Lohmann Brown, Production.  
Abbreviations:  FWPV: Fowlpox virus, FPI: 
Homeopathic preparation Fowlpox Isode, HP: 
Homeopathic preparations, LB: Lohmann 
brown hen, Thuja: Homeopathic preparation 
Thuja occidentalis, TW: Tap Water, Water BP: 
Water and ethanol British pharmacopeia, Im: 
Imitation treatment.  
Introduction 
Fowlpox (FWPV) is an Avipox virus (1) and is 
the only acute Pox virus which affects laying 
hens. In developing countries FWPV may have 
economic importance second only to Newcastle 
disease as, for in many developing countries, 
flock vaccination and biosecurity are 
expensive.  
Homeopathic preparations (HP), which are 
inexpensive and easy to administer, have been 
used in the amelioration of the effects of Pox 
viruses in humans and animals (2, 3), and in the 
modification of response to viral disease in 
animals (4). The possibility of using HP to 
improve animal production and FWPV disease 
control and treatment led to research in the 
Lohmann Brown (LB) which is a common 
backyard and free range hen in southern 
Queensland, as well as a high producing 
commercial hen in Europe. This trial was put in 
place to examine effects of two homeopathic 
preparations Thuja occidentalis (Thuja) and 
FWPV Isode (FPI) on the immune and 
production parameters of Lohmann Brown hen 
in a controlled situation before and after FWPV 
vaccination. The trial studied birds in 
individual cages. 
Materials and Methods 
Four treatment groups of twenty-seven 
individually caged Lohmann Brown hens (LB) 
were each given one drop of the following by 
beak from five to 14 weeks of age: the first 
treatment was the homeopathic preparation 
Thuja occidentalis (Thuja)  made from the 
plant extract, the second was Fowlpox Isode 
(FPI) made from the Webster’s’ Fort dodge 
Fowlpox Vaccine, the third was made from the 
standard homeopathic diluent of mixed water 
and ethanol, British Pharmacopeia (Water BP), 
a fourth was Tap Water (TW). In a fifth 
treatment of 27 birds the handling process of 
dosing was simulated: imitation treatment (Im).  
The FPI was a homeopathic preparation and 
should not be confused with the Fowlpox virus 
(FWPV) live vaccine from which it was made. 
A 30c potency was used weekly for 3 weeks 
before the first FWPV and a 200c daily for 3 
days before the second FWPV. A c potency is a 
one in a hundred dilution of the medicine with 
Water BP.  Egg numbers, body weights, feed 
consumption and body temperature were 
measured. Inoculation site thickness was 
measured after FWPV at 75 and 131 Days 
(age). Phytohemagglutinin injection response 
was measured two weeks after vaccination.   
Results 
Body weight gain of Fowlpox Isode treated 
birds increased (P<0.05) at three weeks after 
layer vaccination, and comb swelling showed 
greater fluctuation in Thuja occidentalis treated 
birds than all others two and four days after the 
layer vaccination.   
 
Table 1: Least Square Means (LSM) differences in BW between 130-146 Days (age), two weeks after 
Fowlpox vaccination and 130-153 Days, three weeks after Fowlpox vaccination ± SE 
 LSM BW  
Difference  g 
Treatment ± SE 
 Days   TW  Water BP  FPI  Thuja Im 
 130-146  -1.4 ± 5ac  -14 ± 4b  -11 ± 6ab  2 ± 4c -9 ± 5ab 
 130-153  -3 ± 5a  -5 ± 4a  12 ± 6b  -12 ± 4a -9 ± 5a 
  
Values with different letters a,b are different (P<0.05), Means are from 810 estimates. T Water: Tap water from 
university supply, Thuja: HP preparation made from Thuja occidentalis, Water BP: HP preparation made from 
water and ethanol British pharmacopeia, homeopathic diluents, FPI: Homeopathic preparation made from FWPV 
vaccine, Im: handling alone, imitation dosing, no medication. 
 
    
 
Figure 1: Least Square Means (LSM) comb thickness (mm) 131-156 Days (age),  
Fowlpox vaccination 131 Days, ± SE TW 1.1, WBP 1.6,   FPI 1.1, Thuja 3.7, Im 1.3 
Means were based on 4,455 estimates. T Water: Tap water, Thuja: HP preparation made from Thuja occidentalis, 
Water BP: HP preparation made from water and ethanol British pharmacopeia, FPI: Homeopathic preparation 
made from FWPV vaccine, Im:  imitation dosing, Arrow marks Fowlpox vaccination. 
 
At 134 days there were differences due to 
treatment (P<0.01). Thuja combs were thicker 
than Im (P < 0.01), but not different to the other 
treatments, which were similar to one another 
(P>0.05) and Im.  At 132 and 134 days soft 
swelling in the Thuja group made measurement 
difficult, denoted by high SE. 
  
 
Figure 2: Least Square Means (LSM) comb thickness (mm) 129-148 Days (age) ± SE 
Means were taken from 2430 estimates. T Water: Tap water, Thuja: HP preparation made from Thuja 
occidentalis, Water BP: HP preparation made from water and ethanol British pharmacopeia, FPI: Homeopathic 
preparation made from FWPV vaccine, Im: handling alone. Arrow shows time of significant difference. 
 
Other parameters measured did not show 
significant changes although there were 
numerous trends which were not significant, 
but may be so, should there be further research 
with larger groups of birds.  
Discussion   
Results showed that HP can affect hen 
responses to FWPV vaccination despite large 
individual hen variation. This means that 
effects of HP are worth further research with 
larger numbers of birds to reduce variation. 
Future trials could occur in different 
commercial situations. Measurement could 
include full blood counts, antibodies, and 
cytokines (interferon) (1).  Blood could be 
sampled after ovalbumin, sheep red blood cell 
and bovine serum inoculation (5, 6), and before 
and after exposure to FWPV, Avian 
encephalitis or ILT, and Marek’s disease.  
Histopathology of inoculation sites after 
vaccination (7) could be examined. As well, 
increasing the potency of homeopathic 
preparations to 1M or 50 M (one in a 100, a 
thousand times, one in a hundred, 50 thousand 
times) may provide greater change.  
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Chicken Infectious Anaemia Virus: An 
Insidious Problem For Conventional and 
SPF Poultry Producers 
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Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, 
Ithaca, NY 14853, USA. Email: kas24@cornell.edu 
Chicken infectious anaemia virus (CIAV or 
CAV) has been recognized as a pathogen since 
1979, but the virus has been present in the USA 
at last since 1959 (12). The economic impact of 
the virus on commercial poultry operations is 
often poorly recognized unless newly hatched 
chicks without maternal antibodies become 
infected before two weeks of age. In the 
majority of commercial flocks infection occurs 
after maternal antibodies wane and subclinical 
immunosuppression may precipitate or enhance 
disease by other pathogens. Protection against 
clinical infection is achieved by vaccination of 
parent flocks if these have not seroconverted 
between 9 to 12 weeks of age by natural 
infection (8,9). Vaccines are also available for 
broilers in the USA, but these have not been 
authorized for use in ovo or in one-day-old 
chicks. There are two important problems in 
developing live CIAV vaccines for in ovo or in 
newly hatched chicks. The first one is that 
maternal antibodies interfere with the 
replication of vaccine virus and development of 
active immunity, which is similar to the 
situation with infectious bursal disease (IBD) 
vaccines. To overcome this problem immune 
complex vaccines have been developed for the 
control of IBD. We have used a similar 
approach for CIAV.  We found that certain 
combinations of antigen and antibodies delay 
virus replication and induce an immune 
response in the absence of anaemia when used 
in maternal antibody-free chicks (10). The 
second problem is how to test for vaccine 
efficacy when vaccinated birds are challenged 
after 2 weeks of age. Using differential 
quantitative PCR with primers specific for 
either the vaccine or challenge virus we showed 
vaccine-induced protection against replication 
of the challenge virus (10). Additional studies 
are needed to determine if immune complex 
vaccines for CIAV are protective under field 
conditions and economically viable. 
 Problems with CIAV infections in 
specific-pathogen-free (SPF) flocks occur 
frequently and often without apparent reason. 
Most often seroconversion is noted in a few 
birds shortly before or after the onset of egg 
production. During the last 12 years we have 
studied the problems of CIAV infections in 
closed SPF flocks maintained by Cornell 
University in a filtered-air, positive-pressure 
(FAPP) house. All birds are housed in colony 
cages with 2 males and 10 to 12 hens/cage. For 
some specific experiments artificial 
insemination (AI) was used to obtain fertilized 
eggs. These flocks were free of CIAV infection 
until 1995 or 1996, when the virus was 
introduced most likely as a consequence of a 
lapse in biosecurity (7). Cardona et al. (2) 
showed that viral DNA can be present in the 
reproductive organs of hens and roosters 
independently of their antibody status. In some 
instances birds seroconverted between 20 and 
30 weeks of age and gonadal tissues were 
positive for viral DNA at the end of the laying 
cycle. Miller et al. (4) examined the importance 
of vertical transmission of viral DNA in several 
experiments. Viral DNA could be detected in 
blastodiscs obtained from 4 antibody-negative 
hens, but viral DNA was only present in 50% 
of the eggs. Similarly, only 1 of 4 semen 
samples from an antibody-negative rooster was 
positive. Eleven roosters that were antibody-
positive for at least 9 weeks prior to semen 
collections still produced positive samples in 
18/47 (38%) of the samples, while 5 other 
roosters in this group were negative. Thus 
intermittent shedding of viral DNA through 
semen and eggs can occur independently of the 
antibody status. Examination of individual 
embryonal organs at 18 days of incubation 
indicated that viral DNA is not germ-line 
transmitted. In another experiment we 
established that eggshell membranes (ESM) 
were a better source for the detection of virus 
than pooled lymphoid organs from 18-day-old 
embryos. In an experiment to study vertical 
transmission and the feasibility to develop true 
negative birds we used four 64-week-old hens, 
which had remained antibody-negative. Each 
hen was inseminated with semen from an 
antibody-negative, virgin male from the same 
flock. Hens and roosters were euthanized 
immediately after egg collection and the 
gonadal tissues were examined for viral DNA; 
one of the roosters had a positive testis. Eggs 
were placed in individual baskets, 8 chicks 
were hatched and immediately after hatching 
placed in an isolator. The ESM were tested by 
nested PCR for the presence of viral DNA and 
two chicks were eliminated because their ESM 
samples were positive. Four birds had positive 
blood samples at 6 weeks of age, one of which 
was also positive at 17 and another was also 
positive at 28 weeks of age, but all six birds 
remained seronegative until termination at 60 
weeks of age. The next generation was obtained 
by mating the two birds that remained viral 
DNA negative and two pairs of birds that had 
viral DNA-positive blood at 6 weeks of age. 
One of these pairs produced a viral DNA-
positive embryo and was eliminated. Twelve 
chicks were hatched from the remaining two 
pairs and one bird from the viral DNA-positive 
pair was positive at 12 weeks of age and 
eliminated. Eight birds were kept until 60 
weeks of age and these remained negative for 
antibodies and viral DNA. This experiment 
showed that it is possible to eliminate carriers, 
but that this will not be an easy process (4). 
These experiments also demonstrated that the 
presence of viral DNA does not always lead to 
active virus replication and seroconversion. The 
combination of our findings led us to postulate 
a latency model for CIAV (7). The latency 
model predicts that viral DNA or virus can be 
transmitted vertically without leading to active 
viral replication unless birds are stressed for 
example when they become sexual mature. 
Viral DNA may remain present as episomal 
double-stranded circular DNA in gonadal 
tissues. Double-stranded circular DNA is 
required for viral replication. 
 We have examined the possibility that 
steroid hormones are involved in the regulation 
of viral transcription by examining the 
promoter/enhancer region of the virus in more 
detail. This region contains 4 direct repeats 
resembling oestrogen response element (ERE) 
consensus half sites, which may bind 
oestrogen-activated oestrogen-receptors. 
Transient transfection experiments using a 
short and a long form of the CIAV promoter 
were used to determine if oestrogen could 
enhance expression of a reporter gene. 
Expression of the reporter gene was indeed 
enhanced when we transfected the oestrogen 
receptor-enhanced LMH/2A cell line with the 
short promoter construct but not with the long 
promoter construct. Thus oestrogen can 
enhance transcription through activation of the 
oestrogen receptor and subsequent binding to 
the ERE (5). This finding is certainly 
compatible with the observation that SPF flocks 
seroconvert shortly before or after egg 
production has started. However to remain 
latent there must also be factors repressing 
transcription. Miller et al. (6) identified two 
repressor complexes. The first one is the 
chicken ovalbumin upstream promoter 
transcription factor 1 (COUP-TF1) which also 
binds to the ERE. The second repressor, 
transcription regulator delta EF-1 binds to a 
nucleotide sequence called E box-like element 
at the transcription start site. In conclusion 
transcriptional activation of viral DNA seems 
to be controlled by at least one positive and two 
negative regulators. 
 Serology is the standard approach to 
monitor the CIAV status of SPF flocks. 
However this may not provide a true picture of 
the presence or absence of CIAV viral DNA in 
a flock. We have recently shown that 
seroconversion rates can fluctuate dramatically 
in the closed SPF flocks at Cornell University 
(11). In contrast to commercial SPF flocks 
where facilities are depopulated at the end of 
the laying cycle and followed by rigorous 
cleaning before the introduction of the new 
flock, the Cornell facility is a truly closed 
system. Chicks are hatched in the same FAPP 
house where 2 to 4 flocks of adult birds are 
kept. Yet we have seen flocks with very low 
seroconversion rates after several flocks with 
high, but less than 100%, seroconversion rates. 
There are at least two explanations for these 
observations. The first one is that a low level of 
continuous horizontal infection from 
seropositive to seronegative birds occurs in the 
facility. However, this does not explain why 
there is a very low seroconversion rate after 
flocks with high seroconversion rates. The 
second explanation is based on the concept of 
latency in which the virus or episomal viral 
DNA is present in the gonads and can be 
transferred to the offspring without causing 
seroconversion.  
 The observations in SPF flocks have 
also consequences for primary breeders in their 
efforts to reduce the presence of CIAV in 
primary lines and grandparent flocks. Brentano 
et al. (1) and recently Hailemariam et al. (3) 
have found that viral DNA can be detected in 
embryos from commercial flocks independently 
of the antibody status. However, it is not clear 
what the practical importance is in view of the 
widespread presence of virus in the field unless 
breeders would be interested in eliminating the 
virus from their pure lines. 
 In conclusion, CIAV has a well-
adapted relationship with its host, in which is 
ensures passage to the next generation avoiding 
elimination by the immune responses. I believe 
that this virus has evolved a long time ago 
probably at the same time that jungle fowl 
evolved. In support of this hypothesis it would 
be of interest to test sera samples from “pure” 
jungle fowl that have not been in contact with 
backyard flocks of chickens or perhaps use 
historic DNA samples, if available, for analysis 
of viral DNA. CIAV will remain a major 
problem especially for the SPF industry but 
also for conventional poultry unless vaccines 
can be developed to prevent the 
immunosuppression associated with infection. 
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 CAV Vaccination, Comparison with Natural 
Exposure in Broilers 
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Abstract: 
Arbor Acres broiler breeder females were 
vaccinated with a commercial CAV vaccine at 
18 weeks of age by intramuscular injection and 
others were left unvaccinated. There was no 
significant difference in the mean titres reached 
in each flock by point of lay, or during later 
production. The study was replicated with 
similar results. This finding questions the value 
of CAV vaccination in the face of an endemic 
challenge in the broiler breeder house. 
Background: 
Chicken Anaemia Virus is a member of the 
Circovirus group which was first reported as 
causing immunosuppression and anaemia in 
infected chickens by Yuasa et al in 1979. The 
virus was reported in Australia by Firth and 
Imai (1990). Vaccine is commercially available 
in Australia and is used to vaccinate broiler 
breeders in order to protect broilers. 
This study was carried out in Victoria, 
Australia in an integrated broiler company in 
which pre-vaccination titres had been noted to 
be at levels generally considered acceptable in 
broiler breeders for protection of broilers. For 
examples titres of all birds in this study were 
over 4,000 ELISA units around 80 – 90 days of 
age and prior to vaccination. 
Materials and methods: 
Shed 1 on the parent rearer farm contained 
11,900 eighteen week old Arbor Acre broiler 
breeders and was treated with Intervet Nobilis 
CAV P4 vaccine (Batch number: 3949-007) by 
intramuscular injection on the 12th of August 
2009. 
A one thousand dose vial of CAV vaccine was 
injected into a 500ml bottle (1,000 doses) of 
Nobilis EDS + ND Combined inactivated 
vaccine against EDS 76 and Newcastle Disease 
(Intervet Australia Pty Ltd). This was injected 
into the breast muscle of each bird at a dose 
rate of 0.5 mL Shed 2 on the same farm also 
was stocked with eighteen week old Arbor 
Acre broiler breeders and was left untreated. 
The study was replicated in sheds 3 and 4 on 
the same farm with the same bird numbers in 
shed 3 and 12,000 in shed 4. Birds in shed 4 
were vaccinated at 18 weeks with the same 
batch of vaccine on the 23rd of September 2009. 
Ten serum samples were collected from each 
group on several occasions up to the age of 53 
and 47 weeks and CAV ELISA testing 
(BioChek Lot Numbers fs4869 & fs4982) was 
performed by Ace Laboratory Services (Lot 3, 
Gildea Lane, Bendigo East, Vic 3550). 
Results and discussion: 
Results from the two replicates are summarised 
below in graphs1 and 2. 
Birds were vaccinated at 18 weeks of age 
(approx 126d) and every bird tested was 
positive (over 725 ELISA units) at all time 
points. The serology indicates that all birds had 
been exposed to CAV prior to vaccination and 
no major serological response to vaccination 
was observed. 
A trend towards a significant difference (P> 
0.13 - two tailed Students t-Test) between 
vaccinates (mean ELISA 4,928) and controls 
(mean ELISA 3,802) at 47 weeks of age in 
sheds 3 and 4 was observed. This was not seen 
in the first replicate of birds (sheds 1 & 2) at 53 
weeks of age. 
 
 Graph1: CAV ELISA titres in broiler breeders from with or without vaccination 
 
Graph 2: CAV ELISA titres in broiler breeders from with or without vaccination 
 
 
The study lends some weight to the following 
hypothesis; in the operation where the study 
was conducted, broiler breeders will be 
exposed to CAV in rear and develop sufficient 
immunity to enable protection of chicks by 
passive transfer of antibodies.  
It is not recommended that broiler breeder 
operations cease CAV vaccination in the 
absence of a history of adequate antibodies 
prior to the normal time of vaccination and 
further serological monitoring post vaccination. 
Statistics 
A Student’s t-Test* was used to examine the 
difference between the 47 week serology of 
sheds 3 and 4. 
  
 t-Test: Two-Sample Assuming Unequal Variances  
    
  BH1 S3 BH1 S4  
Mean 3,801.6 4,927.9  
Variance 2,133,688 2,911,958  
Observations 10 10  
Hypothesized Mean Difference 0   
df 18   
t Stat -1.58561   
P(T<=t) one-tail 0.06512   
t Critical one-tail 1.734064   
P(T<=t) two-tail 0.130239   
t Critical two-tail 2.100922   
• Microsoft Office Excel 2007 Microsoft Corp 
 
References 
Yuassa, N., T. Taniguchi and I. Yoshida.  
Isolation and characteristics of an agent 
inducing anaemia in chicks. Avian Dis. 23: 
366-385. 1979. 
Firth, G. A. and K. Imai. Isolation of chicken 
anaemia agent from Australian poultry. Aus. 
Vet. J. 67:301. 1990. 
 
 Case Report: Avian Nephritis Virus (ANV) 
Infection in a Broiler Flock in Victoria 
Ambrosio “Soy” T. Rubite 
Baiada Poultry 
 
Back in June 2009, a flock of broilers 
in western Victoria exhibited an unusually high 
early mortality around the second week of age, 
starting from one shed and moving rapidly 
across to all four sheds. The affected birds look 
depressed, below target weight and an 
unmistakable respiratory snick/sneeze was 
present. Initial significant post-mortem findings 
revealed severe swelling of the kidneys and 
ureters in all birds examined. Infectious 
bronchitis (IB) infection was first suspected, as 
a possible vaccination reaction but the clinical 
picture-morbidity, mortality and severity of 
renal damage was too difficult to reconcile with 
an IB infection at this age with no other broiler 
farms exhibiting the same problem in spite of 
the same vaccination procedure used in the 
hatchery.  
Kidney samples sent to Melbourne 
University initially picked up the IB vaccine 
strain. However, further testing (PCR) and 
virus isolation yielded the astrovirus-ANV. 
This is one of the first few isolations of this 
virus in Australia. 
It is also surmised that very early 
infection of ANV can possibly cause 
immunosuppression manifesting as increased 
susceptibility to infection from the “normal” 
flora found inside the shed. 
The rest of the presentation discusses 
the effect of ANV on performance parameters 
both in this particular affected flock and the 
subsequent flock followed by the procedures 
undertaken to control this emerging infection.  
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Introduction 
Avian nephritis virus (ANV) is an avian 
Astrovirus that causes significant disease in 
poultry aged up to 14 days old (2, 4, 7, 8) and is 
associated with severe interstitial nephritis. 
Infection with ANV results in growth 
retardation of the affected poultry and therefore 
has negative economic implications. ANV has 
been reported in poultry exhibiting clinical 
signs of renal distress, with similar signs 
observed after experimental infection, but has 
also been repeatedly detected in apparently 
‘healthy’ flocks, including specific pathogen 
free flocks (1, 2, 5-7, 9, 10).  
ANV has very recently been detected in 
Australian chicken flocks in NSW and VIC (3). 
To allow further investigation into ANV in 
Australia, isolation of the virus is required.  
Results 
Swabs and / or kidney tissue were collected 
from 8-11 day old (d.o.) broiler chicken flocks 
in New South Wales and Victoria regardless of 
the current or previous health status of the 
flock. 
The CPE observed in the CEK cells was 
distinct from known Australian avian 
pathogens and embryos from the CAM 
inoculated eggs showed no pathology other 
than a slight dwarfing when compared to non-
inoculated controls. Gross examination of the 
CAMs for all six submissions showed the same 
lesion, but of varying sizes, ranging from 10% 
to 70% of the inoculated area. 
Histopathological examination of infected 
CAMs showed massive ulcerative and necrotic 
lesions. 
Common practice for examination of CEK cells 
inoculated with an unknown avian pathogen is 
to observe, and take initial samples at, 
24 hours p.i. Due to the lack of a live 
characterised ANV to use as a positive control 
in our laboratory, PCR was used for 
confirmation of viral growth. A time trial 
experiment, using submitted renal tissue 
inoculated onto CEK cells, was designed to 
determine if there was an optimal time point for 
detection of ANV by PCR in CEK cells.  
An ANV positive band was produced from the 
inoculated CEK cells at 2 – 4 hour p.i. only. 
This band was subjected to nucleotide 
sequencing and matched the nucleotide 
sequence of the ANV originally detected in the 
kidney tissue.  
Discussion 
There is currently no characterised live 
Australian ANV available for comparison 
against suspected ANV submissions. In 
addition, there is no commercial serological test 
currently available. Thus PCR and nucleotide 
sequencing was used to confirm that ANV had 
grown in CEK cells.  
Our laboratory has extensive experience with 
the culture of a wide range of avian viruses and 
the CPE generated by them. However, the CPE 
found in association with ANV growth in CEK 
cells and the lesions observed on the CAMs 
was dissimilar to all those previously seen in 
our laboratory. It is very likely that other, 
currently uncharacterised, viruses that infect 
chicken kidneys were also present in the 
original tissue submission. 
The successful isolation of an Australian ANV 
lays the foundation for molecular and 
serological identification of the Australian 
ANVs.  
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Introduction 
The so called “Spotty Liver Syndrome” (SLS) 
or Miliary Focal Hepatitis has been a problem 
in adult female hens (meat and layer strain 
breeders and commercial layers) that are kept 
on the floor for many years.  This has been 
particularly so for free range and barn style 
commercial egg producers.  The syndrome 
appears as an acute hepatitis involving a sudden 
onset of mortality and decreased egg 
production mainly seen in flocks in early lay in 
the warmer months of the year.  Culture and 
histological analysis of the livers of these birds 
has not shown the presence of a definitive 
causal bacteria yet the condition responds 
rapidly to antibiotic medication. Several 
attempts at defining the causative agent have 
failed in the recent past and the aetiology 
remains elusive and is in all expectations 
multifactorial. 
The epidemiology of the syndrome is poorly 
understood and comprehensive field 
observational studies are lacking or 
nonexistent.  To this end, we conducted a 
simple mail survey of the free range and barn 
style egg producers in NSW and Victoria over 
the 2008-2009 summer period.  Results are 
presented. 
Materials and Methods 
A simple questionnaire was mailed to all 
identifiable free range and barn layer operations 
within NSW and Victoria (a total of 45 farms), 
asking the farms to report on a flock of layers 
placed in their operation between October and 
February.   
The questionnaire requested information on 
bird age, breed, density, rearing location, barn 
or free range style, vegetation in range, litter 
type, nest type, feed source, worming program, 
occurrence of SLS, who provided the diagnosis, 
any treatment given and its effect and any other 
flock problems (wet litter, cannibalism, 
respiratory disease, other). 
Results 
23 farms responded to the survey (18 NSW, 3 
Vic, and 2 Qld) which was a response rate of 
51%.  Several responded saying that they no 
longer farm birds. Seven farms reported SLS 
over the study period (30% of respondents). 
Five cases were “diagnosed” by a serviceman, 
only 2 by veterinarians. The age of onset varied 
between 25 and 30 weeks.  All cases were 
medicated.  Two cases reported recurrence 
within a few weeks, requiring follow up 
treatment. 
Losses in case farms varied between 16 and 
150 birds (0.5 to 1.0%) prior to treatment. Egg 
production dropped between 0.1% and 15% 
(this was not proportional to bird losses). 
 
No significant associations could be defined 
between the occurrence of SLS and breed 
(P=0.34), vegetation cover of range area 
(P=1.00), wet litter (P=1.00), mash versus 
pelleted feed (P=0.26), home mix versus 
commercial mill feed (P= 0.33), automatic 
nests (P= 0.25), occurrence of worms (P=1.00), 
use of a worming program (P= 0.37), 
occurrence of cannibalism (P=1.00) or 
prolapses (P=0.25) or bird stocking density (P= 
0.71). 
 
On univariate preliminary analysis there were 
some factors showing an interesting association 
with the occurrence of SLS, namely birds 
reared in Victoria (P= 0.02), absence of litter in 
the scratch area (P= 0.17), town water source 
 (P= 0.16) and the number of birds placed (P= 
0.006).  When a multivariate analysis was 
applied to control for the presence of all these 
factors, only flock size remained significant.  
Case flocks averaged 13,683 birds while non 
case flocks averaged only 7,003.  Flocks with 
more than 12,000 birds appeared to be more at 
risk and this was not associated with stocking 
density. 
Discussion 
This was a simple survey and the results may 
be subject to considerable confounding.  The 
association with flock size however was 
considerably strong.  Flock size on its own may 
be a surrogate risk factor for another underlying 
factor which is strongly correlated to it but was 
not measured by the information gathered.  It is 
hypothesised that the real risk factor may relate 
to actual available feed space.  Many flocks 
have slatted areas adjoining the nest boxes and 
drinkers and waterers are placed over this slat 
area to encourage birds to use the nests.  In 
some cases, the feed lines are very close to the 
edge of the slats.  It is hypothesised that in hot 
weather when the birds are approaching peak 
egg production and are at their hungriest, that 
birds leaving the nest boxes and crowding to 
the feeders may push the feed lines close to the 
edge of the slatted area, thus decreasing real 
feed space availability.  This “stress” may be 
the factor which predisposes the flock to the 
occurrence of SLS.  This possibility has 
considerable anecdotal support (R. Horn, pers. 
comm., C. Owens, pers. comm.). 
This hypothesis needs to be investigated by a 
more thorough study focussing only on flocks 
above 12,000 birds during a summer period.  If 
confirmed, this would provide a tool to control 
or eliminate this disease from the industry 
without the need to discover the identity of the 
causative organism(s) involved. 
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Introduction 
Re-use of litter will, in the future, be a key 
issue particularly availability and quality of 
suitable bedding material.  Currently re-use is 
practiced in Queensland as an alternative to 
sourcing new bedding for each cycle.  Re-use 
will also address issues around the disposal of 
used litter to the environment.  However there 
is an absence of scientific data to support the 
re-use of litter.  This lack of data has lead to 
concerns from time to time on the possible 
transfer of pathogens from cycle to cycle via 
used litter or even a build up in pathogen levels 
following sequential production cycles.  
However in countries such as the USA, full re-
use of litter does commonly occur for an 
extended period of time.   
The national data for gastrointestinal illnesses 
in Australia in 2009 list Campylobacteriosis 
(15,841 cases) and Salmonellosis (9,523 cases) 
as the two major causes of gastrointestinal 
illness (Australian Government, Department of 
Health and Ageing).  This creates pressure on 
the poultry industry as both organisms are 
normal inhabitants of poultry.  Knowledge of 
the effects on both Campylobacter and Salmonella 
levels when litter is re-used would create better 
understanding of the impact of commonly 
adopted re-use practices and the survival 
potential of these key pathogens.  
The recently completed CRC project (Re-use of 
chicken litter across broiler cycles – managing 
the food-borne pathogen risk, 2006-2008) and 
the current RIRDC project (Evaluating food-
borne pathogen transfer associated with partial 
and full re-use litter 2008-2011) were both 
designed to address the relationships of both 
Salmonella and Campylobacter during re-use.  
The CRC study dealt with litter treatment (i.e. 
litter windrowing/piling) between cycles and 
the RIRDC study (in progress) deals with the 
impact of re-used litter on pathogen levels in 
both the chicken caeca as well in litter used 
through the different production cycles.  
In the current RIRDC project, we are working 
on understanding the dynamics of these two 
pathogens during three different litter 
management practices, i.e. fresh bedding each 
cycle, a common Australian practice (partial re-
use) and full re-use.  One shed has been 
dedicated to each litter management practice.  
The current study deals with comparing these 
three production practices on a single farm 
under commercial conditions.  The full study is 
looking at possible pathogen transfer across 
cycles via the litter and is designed to test six 
sequential cycles with re-use litter (both full 
and partial) being used for almost a year.  The 
shed operating conditions as well as key 
physical parameters (Moisture and pH) of litter 
are also being monitored during production.   
This study is still in progress.  Initial outcomes 
suggest there is little difference across the three 
sheds (levels in litter and levels in caecum) 
through sequential cycles even with the use of 
varying litter practices.  An overview of these 
outcomes will be discussed.  At this early stage, 
there appears to be a potential to re-use litter 
based on either practices of re-use being 
studied.  
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Introduction 
 
Re-use of litter by broiler chickens can reduce 
the cost and environmental impact of 
production but uptake of the practice is limited 
largely by the risk of pathogen carryover 
between batches. On a recent project funded by 
the Australian Poultry CRC (Project 06-15) our 
research team developed an effective chick 
bioassay to measure viral infectivity in litter 
(1). We also conducted field experiments 
investigating the effects of various litter 
heaping treatments on decay of viral infectivity 
over 9-10 days (2) and associated temperature, 
pH, moisture and litter chemistry measurements 
(3,4).  
One objective of this work was to link the 
temperatures and other changes achieved 
during litter treatments to the rate of pathogen 
inactivation as determined by bioassay of litter 
infectivity. Ideally such information would be 
generated for the complete range of viral 
pathogens, but a problem with the approach 
taken was that sometimes there was a limited 
range of pathogens on a given farm in question. 
One solution would be to experimentally infect 
chickens and thus litter with a wide range of 
pathogens, but it is difficult and expensive to 
do this on scale which would generate 
sufficient litter for composting studies that 
would mimic the field situation. Another 
problem with wider application of methodology 
to measure viral pathogen load in litter is the 
comparatively high cost of the chick bioassay. 
Methods, results and discussion 
 
In 2009 the Poultry CRC funded a short project 
(09-34) to test proof of concept of approaches 
to overcoming the issues raised above. To 
better determine temperature/time requirements 
for virus inactivation we deliberately generated 
infective litter with vaccinal strains of the 
major viral pathogens, then exposed this litter, 
together with “dirty” end of batch field litter to 
temperatures of 50, 60 or 70˚C in incubators for 
10 days.  Samples taken on days 0 (before 
heating), 5 and 10 of these treatments were 
tested for the presence of viral pathogens using 
the chick bioassay. To examine the possibility 
of molecular detection of viral pathogen load 
directly from litter, we undertook preliminary 
investigations into molecular quantification of 
MDV in litter material. Results are summarised 
below. 
Production of infective litter and transmission 
of pathogens in day 0 litter (prior to heat 
treatments). 
 Forty commercial broiler chickens were used 
as shedder birds to produce contaminated litter.  
Between days 17 and 28 they were infected 
with vaccinal strains of IBDV, NDV, IBV, 
MDV, CAV (old Steggles vaccine), Fowl pox 
virus, ILTV and AEV.  At day 35, when litter 
was collected for treatment and testing, birds 
were serologically positive for CAV, MDV, 
ND, IBD, IB and ILT although the response to 
the latter was low. The low sero-conversion 
rate for ILT was probably because blood 
samples were collected only 8 days after 
vaccination. The chickens were not positive for 
AE antibody possibly because serum was 
collected only 7 days after vaccination. 
Seroconversion to fowl pox was not measured, 
 as we did not have an assay for it. Litter from 
the UNE shedder chicks resulted in successful 
litter transmission of MDV and CAV only. 
There was no litter transmission of IBV, NDV, 
IBDV, ILTV or AE from these chicks despite 
the shedder chicks being seropositive at the 
time of litter collection. This may be due to 
lack of shedding of virus (wrong window of 
time, low shedding rates) or failure of the virus 
to transmit on litter. We know that IBV and 
NDV transmit poorly on litter (Islam et al., 
2010a) but that IBDV will, and in this 
experiment the field litter was also sporadically 
infectious for IBDV. This suggests that our 
model for generating infectious litter requires 
refinement and measurement of actual viral 
shedding in addition to seroconversion.  
The pooled field litter contained highly 
infectious FAV, for which we did not have 
challenge virus at UNE. It was also infectious 
for MDV, CAV and IBDV (sporadically).  
Virus inactivation over time at different 
temperatures.   
FAV infectivity was lost by day 5 at all 
temperatures (50, 60 and 70˚C) . CAV 
infectivity was lost by day 5 at 60 and 70˚C and 
by day 10 at 50˚C. Data for IBDV (in the field 
litter) were inconclusive, however there was no 
infectivity detected by day 10. However 
significant MDV infectivity was maintained at 
day 10 for all temperatures for the field litter, 
and at 50˚C for the UNE litter. Temperature 
effects could not be tested for IBV, NDV and 
ILT as there was no apparent litter transmission 
at all. 
Detection and quantification of viral DNA 
directly from litter.  
We were able to directly measure MDV viral 
load in litter using a simple protocol on our 1st 
attempt. However there was a poor association 
with the level of infectivity determined by the 
chick bioassay. Due to strange pattern of MDV 
infectivity in this experiment and because 
methods of viral quantification from litter had 
not been optimised we feel that this approach is 
worthy of further investigation on a wider 
range of viruses with clearer patterns of 
inactivation. 
Conclusions  
 
In broad terms proof of concept was confirmed 
for: 
• Laboratory level heat treatment of litter, 
coupled with bioassay of infectivity, to 
better define temperature/time 
interaction for inactivation of pathogens 
in litter;  
• direct detection and quantification of 
viral pathogens in litter. 
This offers promise for a future situation where 
infective viral pathogen load in litter is 
measured directly and the effects of between 
batch litter treatments on viral inactivation are 
readily determined by direct methods. 
Nevertheless significant challenges remain 
before this becomes a reality. These include: 
• Optimising chick challenge methods to 
guarantee infective litter during the 
experimental phase; 
• Optimising methods of extracting and 
quantifying viral nucleic acids from 
litter; 
• Defining the relationship between decay 
in molecular detection and decay in 
infectivity for different pathogens. The 
two may not necessarily coincide (5). 
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 Identification of Chlamydial Species in 
Chickens by PCR-HRM Curve Analysis 
T. Robertson, S. Bibby, D. O’Rourke, T. Belfiore, R. Agnew-Crumpton 
and A. H. Noormohammadi 
 
Recently, a PCR protocol (16SG), 
targeting 16S rRNA gene coupled with high 
resolution melt (HRM) curve analysis was 
developed in our laboratory and shown to 
reliably detect and identify the seven different 
Chlamydiaceae spp.  In this study, the potential 
of this method was assessed for detection and 
differentiation of Chlamydiosis in clinical 
specimens.  Of the total number of 733 
specimens from a range of animal species, 199 
(27%) were found positive by 16SG PCR.  
These included 27 positive specimens from a 
total number of 306 chicken specimens. When 
a sufficient amount of DNA was available (9 
chicken submissions), amplicons generated by 
the 16SG PCR were subjected to HRM curve 
analysis and results were compared to that of 
nucleotide sequencing.  Analysis of the HRM 
curves and nucleotide sequences from 16SG 
PCR amplicons revealed the occurrence of a 
Chlamydophila-like, a Parachlamydia-like and 
a variant of Chlamydophila psittaci in chickens. 
These results reveal the potential of 16SG 
PCR-HRM curve analysis for rapid and 
simultaneous detection and identification of 
Chlamydiaceae spp. in chickens. 
 
